Cover Page
Cover Page - shares | 9 Months Ended | |
Dec. 31, 2020 | Jan. 29, 2021 | |
Entity Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Dec. 31, 2020 | |
Document Transition Report | false | |
Entity File Number | 001-38033 | |
Entity Registrant Name | DXC Technology Co | |
Entity Incorporation, State or Country Code | NV | |
Entity Tax Identification Number | 61-1800317 | |
Entity Address, Address Line One | 1775 Tysons Boulevard | |
Entity Address, City or Town | Tysons | |
Entity Address, State or Province | VA | |
Entity Address, Postal Zip Code | 22102 | |
City Area Code | 703 | |
Local Phone Number | 245-9675 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 254,593,993 | |
Entity Central Index Key | 0001688568 | |
Current Fiscal Year End Date | --03-31 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false | |
Common Stock | ||
Entity Information [Line Items] | ||
Title of 12(b) Security | Common Stock, $0.01 par value per share | |
Trading Symbol | DXC | |
Security Exchange Name | NYSE | |
Senior notes due 2025 | ||
Entity Information [Line Items] | ||
Title of 12(b) Security | 2.750% Senior Notes Due 2025 | |
Trading Symbol | DXC 25 | |
Security Exchange Name | NYSE | |
Senior notes due 2026 | ||
Entity Information [Line Items] | ||
Title of 12(b) Security | 1.750% Senior Notes Due 2026 | |
Trading Symbol | DXC 26 | |
Security Exchange Name | NYSE |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Statement [Abstract] | ||||
Revenues | $ 4,288 | $ 5,021 | $ 13,344 | $ 14,762 |
Costs of services (excludes depreciation and amortization and restructuring costs) | 3,333 | 3,827 | 10,525 | 11,128 |
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) | 517 | 518 | 1,595 | 1,514 |
Depreciation and amortization | 475 | 479 | 1,492 | 1,416 |
Goodwill impairment losses | 0 | 53 | 0 | 2,940 |
Restructuring costs | 104 | 74 | 441 | 248 |
Interest expense | 82 | 93 | 284 | 288 |
Interest income | (28) | (33) | (76) | (130) |
Gain on disposition of businesses | (2,046) | 0 | (2,046) | 0 |
Gain on arbitration award | 0 | 0 | 0 | (632) |
Other income, net | (127) | (117) | (318) | (344) |
Total costs and expenses | 2,310 | 4,894 | 11,897 | 16,428 |
Income (loss) before income taxes | 1,978 | 127 | 1,447 | (1,666) |
Income tax expense | 875 | 37 | 789 | 191 |
Net income (loss) | 1,103 | 90 | 658 | (1,857) |
Less: net income attributable to non-controlling interest, net of tax | 5 | 8 | 9 | 17 |
Net income (loss) attributable to DXC common stockholders | $ 1,098 | $ 82 | $ 649 | $ (1,874) |
Earnings Per Share [Abstract] | ||||
Basic (in dollars per share) | $ 4.32 | $ 0.32 | $ 2.55 | $ (7.20) |
Diluted (in dollars per share) | $ 4.29 | $ 0.32 | $ 2.54 | $ (7.20) |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | |||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | ||
Statement of Comprehensive Income [Abstract] | |||||
Net income (loss) | $ 1,103 | $ 90 | $ 658 | $ (1,857) | |
Other comprehensive income, net of taxes: | |||||
Foreign currency translation adjustments, net of tax | [1] | 170 | 293 | 200 | 87 |
Cash flow hedges adjustments, net of tax | [2] | 0 | (8) | 18 | (6) |
Available-for-sale securities, net of tax | [3] | (11) | 0 | (6) | 2 |
Prior service cost, net of tax | [4] | (1) | 0 | (1) | 0 |
Pension and other post-retirement benefit plans, net of tax: | |||||
Amortization of prior service cost, net of tax | [5] | (2) | (2) | (12) | (6) |
Pension and other post-retirement benefit plans, net of tax | (3) | (2) | (13) | (6) | |
Other comprehensive income, net of taxes | 156 | 283 | 199 | 77 | |
Comprehensive income (loss) | 1,259 | 373 | 857 | (1,780) | |
Less: comprehensive income attributable to non-controlling interest | 6 | 39 | 12 | 26 | |
Comprehensive income (loss) attributable to DXC common stockholders | $ 1,253 | $ 334 | $ 845 | $ (1,806) | |
[1] | Tax benefit related to foreign currency translation adjustments was $9 and $31 for the three and nine months ended December 31, 2020, respectively, and $15 and $2 for the three and nine months ended December 31, 2019, respectively. | ||||
[2] | Tax expense related to cash flow hedge adjustments was $0 and $6 for the three and nine months ended December 31, 2020, respectively. Tax benefit related to cash flow hedge adjustments was $1 and $1 for the three and nine months ended December 31, 2019, respectively. | ||||
[3] | Tax benefit related to available-for-sale securities was $4 for the three and nine months ended December 31, 2020. Tax expense related to available-for-sale securities was $0 and $1 for the three and nine months ended December 31, 2019, respectively. | ||||
[4] | There was no tax benefit related to prior service costs during the three and nine months ended December 31, 2020 and December 31, 2019, respectively. | ||||
[5] | Tax benefit related to amortization of prior service costs was $1 and $3 for the three and nine months ended December 31, 2020, respectively, and $0 and $1 for the three and nine months ended December 31, 2019, respectively. |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) (Parenthetical) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Statement of Comprehensive Income [Abstract] | ||||
Foreign currency translation adjustments, tax expense (benefit) | $ (9) | $ (15) | $ (31) | $ (2) |
Cash flow hedges adjustments, tax expense (benefit) | 0 | (1) | 6 | (1) |
Tax expense (benefit) related to available-for-sale securities | (4) | 0 | (4) | 1 |
Prior service cost, tax | 0 | 0 | 0 | 0 |
Amortization of prior service cost, tax benefit | $ 1 | $ 0 | $ 3 | $ 1 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Millions | Dec. 31, 2020 | Mar. 31, 2020 |
Current assets: | ||
Cash and cash equivalents | $ 3,919 | $ 3,679 |
Receivables and contract assets, net of allowance of $199 and $74 | 4,130 | 4,392 |
Prepaid expenses | 586 | 646 |
Other current assets | 470 | 270 |
Total current assets | 9,105 | 8,987 |
Intangible assets, net of accumulated amortization of $4,545 and $4,347 | 4,019 | 5,731 |
Operating right-of-use assets, net | 1,459 | 1,428 |
Goodwill | 736 | 2,017 |
Deferred income taxes, net | 315 | 265 |
Property and equipment, net of accumulated depreciation of $4,295 and $3,818 | 3,321 | 3,547 |
Other assets | 4,679 | 4,031 |
Total Assets | 23,634 | 26,006 |
Current liabilities: | ||
Short-term debt and current maturities of long-term debt | 795 | 1,276 |
Accounts payable | 852 | 1,598 |
Accrued payroll and related costs | 741 | 630 |
Current operating lease liabilities | 450 | 482 |
Accrued expenses and other current liabilities | 3,285 | 2,801 |
Deferred revenue and advance contract payments | 1,102 | 1,021 |
Income taxes payable | 1,045 | 87 |
Total current liabilities | 8,270 | 7,895 |
Long-term debt, net of current maturities | 5,444 | 8,672 |
Non-current deferred revenue | 666 | 735 |
Non-current operating lease liabilities | 1,113 | 1,063 |
Non-current income tax liabilities and deferred tax liabilities | 792 | 1,157 |
Other long-term liabilities | 1,354 | 1,355 |
Total Liabilities | 17,639 | 20,877 |
Commitments and contingencies | ||
DXC stockholders’ equity: | ||
Preferred stock, par value $.01 per share, 1,000,000 shares authorized, none issued as of December 31, 2020 and March 31, 2020 | 0 | 0 |
Common stock, par value $.01 per share, 750,000,000 shares authorized, 256,800,719 issued as of December 31, 2020 and 255,674,040 issued as of March 31, 2020 | 3 | 3 |
Additional paid-in capital | 10,748 | 10,714 |
Accumulated deficit | (4,533) | (5,177) |
Accumulated other comprehensive loss | (407) | (603) |
Treasury stock, at cost, 2,410,917 and 2,148,708 shares as of December 31, 2020 and March 31, 2020 | (156) | (152) |
Total DXC stockholders’ equity | 5,655 | 4,785 |
Non-controlling interest in subsidiaries | 340 | 344 |
Total Equity | 5,995 | 5,129 |
Total Liabilities and Equity | $ 23,634 | $ 26,006 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($) $ in Millions | Dec. 31, 2020 | Mar. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $ 199 | $ 74 |
Intangible assets, accumulated amortization | 4,545 | 4,347 |
Property and equipment, accumulated depreciation | $ 4,295 | $ 3,818 |
DXC stockholders’ equity: | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, authorized (in shares) | 1,000,000 | 1,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, authorized (in shares) | 750,000,000 | 750,000,000 |
Common stock, issued (in shares) | 256,800,719 | 255,674,040 |
Common stock in treasury, at cost (in shares) | 2,410,917 | 2,148,708 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Millions | 9 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Cash flows from operating activities: | ||
Net income (loss) | $ 658 | $ (1,857) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 1,506 | 1,429 |
Goodwill impairment losses | 0 | 2,940 |
Operating right-of-use expense | 463 | 506 |
Pension and other post-employment benefits, actuarial and settlement losses | 2 | 0 |
Share-based compensation | 42 | 57 |
Deferred taxes | (319) | (28) |
(Gain) loss on dispositions | (2,023) | 6 |
Provision for losses on accounts receivable | 52 | 0 |
Unrealized foreign currency exchange (gain) loss | (60) | 14 |
Impairment losses and contract write-offs | 68 | 20 |
Other non-cash charges, net | (2) | (13) |
Changes in assets and liabilities, net of effects of acquisitions and dispositions: | ||
Decrease in assets | 88 | 141 |
Decrease in operating lease liability | (463) | (506) |
Increase (decrease) in other liabilities | 392 | (647) |
Net cash provided by operating activities | 404 | 2,062 |
Cash flows from investing activities: | ||
Purchases of property and equipment | (215) | (240) |
Payments for transition and transformation contract costs | (189) | (220) |
Software purchased and developed | (209) | (178) |
Payments for acquisitions, net of cash acquired | (10) | (1,997) |
Business dispositions | 4,942 | 0 |
Cash collections related to deferred purchase price receivable | 159 | 513 |
Proceeds from sale of assets | 27 | 55 |
Short-term investing | 0 | (75) |
Other investing activities, net | (5) | 20 |
Net cash provided by (used in) investing activities | 4,500 | (2,122) |
Cash flows from financing activities: | ||
Borrowings of commercial paper | 854 | 4,010 |
Repayments of commercial paper | (1,327) | (3,893) |
Borrowings under lines of credit | 2,500 | 0 |
Repayment of borrowings under lines of credit | (4,000) | 0 |
Borrowings on long-term debt, net of discount | 993 | 2,198 |
Principal payments on long-term debt | (2,926) | (1,029) |
Payments on finance leases and borrowings for asset financing | (694) | (646) |
Proceeds from stock options and other common stock transactions | 1 | 11 |
Taxes paid related to net share settlements of share-based compensation awards | (5) | (15) |
Repurchase of common stock and advance payment for accelerated share repurchase | 0 | (736) |
Dividend payments | (53) | (161) |
Other financing activities, net | (14) | (44) |
Net cash used in financing activities | (4,671) | (305) |
Effect of exchange rate changes on cash and cash equivalents | 20 | 26 |
Net increase (decrease) in cash and cash equivalents including cash classified within current assets held for sale | 253 | (339) |
Less: cash classified within current assets held for sale | (13) | 0 |
Net increase (decrease) in cash and cash equivalents | 240 | (339) |
Cash and cash equivalents at beginning of year | 3,679 | 2,899 |
Cash and cash equivalents at end of period | $ 3,919 | $ 2,560 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (unaudited) - USD ($) $ in Millions | Total | Common Stock | Additional Paid-in Capital | Retained Earnings (Accumulated Deficit) | Accumulated Other Comprehensive Loss | Treasury Stock | Total DXC Equity | Non- Controlling Interest | Cumulative Effect, Period of Adoption, Adjustment | Cumulative Effect, Period of Adoption, AdjustmentRetained Earnings (Accumulated Deficit) | Cumulative Effect, Period of Adoption, AdjustmentTotal DXC Equity | |
Balance (in shares) at Mar. 31, 2019 | 270,214,000 | |||||||||||
Beginning balance at Mar. 31, 2019 | $ 11,725 | $ 3 | $ 11,301 | $ 478 | $ (244) | $ (136) | $ 11,402 | $ 323 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Net income (loss) | (1,857) | (1,874) | (1,874) | 17 | ||||||||
Other comprehensive income | 77 | 68 | 68 | 9 | ||||||||
Share-based compensation expense | 55 | 55 | 55 | |||||||||
Acquisition of treasury stock | (15) | (15) | (15) | |||||||||
Share repurchase program (in shares) | (15,934,000) | |||||||||||
Share repurchase program | (736) | (669) | (67) | (736) | ||||||||
Stock option exercises and other common stock transactions (in shares) | 1,326,000 | |||||||||||
Stock option exercises and other common stock transactions | 14 | 14 | 14 | |||||||||
Dividends declared | (165) | (165) | (165) | |||||||||
Non-controlling interest distributions and other | 3 | 0 | 3 | |||||||||
Balance (in shares) at Dec. 31, 2019 | 255,606,000 | |||||||||||
Ending balance at Dec. 31, 2019 | 9,101 | $ 3 | 10,701 | (1,628) | (176) | (151) | 8,749 | 352 | ||||
Balance (in shares) at Mar. 31, 2019 | 270,214,000 | |||||||||||
Beginning balance at Mar. 31, 2019 | $ 11,725 | $ 3 | 11,301 | 478 | (244) | (136) | 11,402 | 323 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Accounting Standards Update [Extensible List] | us-gaap:AccountingStandardsUpdate201613Member | |||||||||||
Balance (in shares) at Mar. 31, 2020 | 255,674,000 | |||||||||||
Ending balance at Mar. 31, 2020 | $ 5,129 | $ 3 | 10,714 | (5,177) | (603) | (152) | [1] | 4,785 | 344 | $ (4) | $ (4) | $ (4) |
Balance (in shares) at Sep. 30, 2019 | 257,626,000 | |||||||||||
Beginning balance at Sep. 30, 2019 | 8,870 | $ 3 | 10,793 | (1,668) | (428) | (150) | 8,550 | 320 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Net income (loss) | 90 | 82 | 82 | 8 | ||||||||
Other comprehensive income | 283 | 252 | 252 | 31 | ||||||||
Share-based compensation expense | 6 | 6 | 6 | |||||||||
Acquisition of treasury stock | (1) | (1) | (1) | |||||||||
Share repurchase program (in shares) | (2,354,000) | |||||||||||
Share repurchase program | (86) | (98) | 12 | (86) | ||||||||
Stock option exercises and other common stock transactions (in shares) | 334,000 | |||||||||||
Dividends declared | (54) | (54) | (54) | |||||||||
Non-controlling interest distributions and other | (7) | 0 | (7) | |||||||||
Balance (in shares) at Dec. 31, 2019 | 255,606,000 | |||||||||||
Ending balance at Dec. 31, 2019 | $ 9,101 | $ 3 | 10,701 | (1,628) | (176) | (151) | 8,749 | 352 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Treasury shares (in shares) | 2,148,708 | |||||||||||
Balance (in shares) at Mar. 31, 2020 | 255,674,000 | |||||||||||
Beginning balance at Mar. 31, 2020 | $ 5,129 | $ 3 | 10,714 | (5,177) | (603) | (152) | [1] | 4,785 | 344 | $ (4) | $ (4) | $ (4) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Net income (loss) | 658 | 649 | 649 | 9 | ||||||||
Other comprehensive income | 199 | 196 | 196 | 3 | ||||||||
Share-based compensation expense | 33 | 33 | 33 | |||||||||
Acquisition of treasury stock | (4) | (4) | [1] | (4) | ||||||||
Stock option exercises and other common stock transactions (in shares) | 1,127,000 | |||||||||||
Stock option exercises and other common stock transactions | 1 | 1 | 1 | |||||||||
Non-controlling interest distributions and other | (17) | (1) | (1) | (16) | ||||||||
Balance (in shares) at Dec. 31, 2020 | 256,801,000 | |||||||||||
Ending balance at Dec. 31, 2020 | 5,995 | $ 3 | 10,748 | (4,533) | (407) | (156) | [1] | 5,655 | 340 | |||
Balance (in shares) at Sep. 30, 2020 | 256,522,000 | |||||||||||
Beginning balance at Sep. 30, 2020 | 4,751 | $ 3 | 10,746 | (5,631) | (562) | (155) | [1] | 4,401 | 350 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Net income (loss) | 1,103 | 1,098 | 1,098 | 5 | ||||||||
Other comprehensive income | 156 | 155 | 155 | 1 | ||||||||
Share-based compensation expense | 1 | 1 | 1 | |||||||||
Acquisition of treasury stock | (1) | (1) | [1] | (1) | ||||||||
Stock option exercises and other common stock transactions (in shares) | 279,000 | |||||||||||
Stock option exercises and other common stock transactions | 1 | 1 | 1 | |||||||||
Non-controlling interest distributions and other | (16) | 0 | (16) | |||||||||
Balance (in shares) at Dec. 31, 2020 | 256,801,000 | |||||||||||
Ending balance at Dec. 31, 2020 | $ 5,995 | $ 3 | $ 10,748 | $ (4,533) | $ (407) | $ (156) | [1] | $ 5,655 | $ 340 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Treasury shares (in shares) | 2,410,917 | |||||||||||
[1] | 2,410,917 treasury shares as of December 31, 2020. |
CONDENSED CONSOLIDATED STATEM_6
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (unaudited) (Parenthetical) - $ / shares | 3 Months Ended | 9 Months Ended |
Dec. 31, 2019 | Dec. 31, 2019 | |
Statement of Stockholders' Equity [Abstract] | ||
Cash dividends declared (in dollars per share) | $ 0.21 | $ 0.63 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Business DXC Technology Company ("DXC," the "Company," "we," "us," or "our") helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy its enterprise technology stack to deliver new levels of performance, competitiveness and customer experiences. HHS Sale On October 1, 2020, DXC completed the sale of its U.S. State and Local Health and Human Services business ("HHS" or the "HHS Business") to Veritas Capital Fund Management, L.L.C. ("Veritas Capital") to form Gainwell Technologies. The sale was accomplished by the cash purchase of all equity interests and assets attributable to the HHS Business together with future services to be provided by the Company for a total enterprise value of $5.0 billion, subject to net working capital adjustments and assumed liabilities. See Note 4 - Divestitures for further information. HPS Sale On July 17, 2020, DXC entered into a purchase agreement to sell (the "HPS Sale") its healthcare provider software business ("HPS" or the "HPS Business") to Dedalus Holding S.p.A. ("Dedalus") for €459 million (approximately $525 million), subject to certain adjustments. The HPS Sale is expected to close by March 2021, subject to meeting certain closing conditions. Luxoft Acquisition On June 14, 2019, DXC completed its acquisition of Luxoft Holding, Inc. ("Luxoft"), a global digital strategy and software engineering firm (the "Luxoft Acquisition"). The acquisition builds on DXC’s unique value proposition as an end-to-end, mainstream IT and digital services market leader, and strengthens the Company’s ability to design and deploy transformative digital solutions for clients at scale. See Note 3 - "Acquisitions" for further information. Basis of Presentation In order to make this report easier to read, DXC refers throughout to (i) the interim unaudited Condensed Consolidated Financial Statements as the “financial statements,” (ii) the Condensed Consolidated Statements of Operations as the “statements of operations,” (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss) as the "statements of comprehensive income," (iv) the Condensed Consolidated Balance Sheets as the “balance sheets,” and (v) the Condensed Consolidated Statements of Cash Flows as the “statements of cash flows.” In addition, references throughout to numbered “Notes” refer to the numbered Notes in these Notes to Condensed Consolidated Financial Statements, unless otherwise noted. The accompanying financial statements include the accounts of DXC, its consolidated subsidiaries, and those business entities in which DXC maintains a controlling interest. Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. Other investments are accounted for by the cost method. Non-controlling interests are presented as a separate component within equity in the balance sheets. Net earnings attributable to the non-controlling interests are presented separately in the statements of operations and comprehensive income attributable to non-controlling interests are presented separately in the statements of comprehensive income. All intercompany transactions and balances have been eliminated. Certain amounts reported in the previous year have been reclassified to conform to the current year presentation. The financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission for quarterly reports and accounting principles generally accepted in the United States ("GAAP"). Certain disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules. These financial statements should therefore be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2020 ("fiscal 2020"). Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions that affect amounts reported in the financial statements. The Company bases its estimates on assumptions regarding historical experience, currently available information and anticipated developments that it believes are reasonable and appropriate. However, because the use of estimates involves an inherent degree of uncertainty, actual results could differ from those estimates. The severity, magnitude and duration, as well as the economic consequences of the coronavirus disease 2019 ("COVID-19") pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of the Company's management, the accompanying financial statements of DXC contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company's financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full fiscal year. Allowance for Credit Losses Effective April 1, 2020, the Company adopted Accounting Standards Update ("ASU") 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” using the modified retrospective method. Refer to Note 2 - "Recent Accounting Pronouncements" and Note 6 - "Receivables" for further discussion of the impact of adoption and other required disclosures. The amendments in this update changed the guidance for credit losses to an expected loss model rather than an incurred loss model. Financial assets subject to impairment under an expected credit loss model include billed and unbilled receivables, other receivables, and contract assets. Certain off-balance sheet arrangements, such as financial guarantees associated with receivables securitization facilities, are also subject to the guidance of ASU 2016-13. Under an expected credit loss model, the Company immediately recognizes an estimate of credit losses expected to occur over the remaining life of financial assets that are in the scope of ASU 2016-13. DXC considers all available relevant information when estimating expected credit losses, including past events, current market conditions and forecasts and their implications for expected credit losses. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 9 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Recent Accounting Pronouncements | Recent Accounting Pronouncements During the nine months ended December 31, 2020, DXC adopted the following Accounting Standards Updates ("ASU") issued by the Financial Accounting Standards Board: Date Issued and ASU Date Adopted and Method Description Impact June 2016 ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” April 1, 2020 Modified Retrospective This update requires the measurement and recognition of expected credit losses using the current expected credit loss model for financial assets held at amortized cost, which includes the Company’s trade accounts receivable, certain financial instruments and contract assets. It replaces the existing incurred loss impairment model with an expected loss methodology. The recorded credit losses are adjusted each period for changes in expected lifetime credit losses. The standard requires a cumulative effect adjustment to the statement of financial position as of the beginning of the first reporting period in which the guidance is effective. The Company adopted this standard using the modified retrospective approach and recorded an immaterial cumulative effect adjustment in retained earnings as of April 1, 2020. August 2018 ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract" April 1, 2020 Prospective This update helps entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license. Entities have the option to apply this standard prospectively to all implementation costs incurred after the date of adoption or retrospectively. The Company adopted this standard using the prospective method and determined that the adoption of ASU 2018-15 had no material impact to its condensed consolidated financial statements. The following ASUs were recently issued but have not yet been adopted by DXC: Date Issued and ASU DXC Effective Date Description Impact December 2019 ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" Fiscal 2022 This update is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. Early adoption of this update is permitted. The Company is currently evaluating the potential impact this standard may have on its financial statements in future reporting periods. Other recently issued ASUs effective after December 31, 2020 are not expected to have a material effect on DXC's consolidated financial statements. |
Acquisitions
Acquisitions | 9 Months Ended |
Dec. 31, 2020 | |
Business Combinations [Abstract] | |
Acquisitions | Acquisitions Fiscal 2020 Acquisitions Luxoft Acquisition On June 14, 2019, DXC completed the acquisition of Luxoft, a digital service provider whose offerings encompass strategic consulting, custom software development services, and digital solution engineering for total consideration of $2.0 billion. In return, DXC received all of Luxoft's issued and outstanding Class A and Class B ordinary shares. The acquisition will combine Luxoft’s digital engineering capabilities with DXC’s expertise in IT modernization and integration. The purchase agreement (“Merger Agreement”) was entered into by DXC and Luxoft on January 6, 2019 and the transaction was closed on June 14, 2019 (the "acquisition date.") The transaction between DXC and Luxoft is an acquisition, with DXC as the acquirer and Luxoft as the acquiree, based on the fact that DXC acquired 100% of the equity interests and voting rights in Luxoft, and that DXC is the entity that transferred the cash consideration. The Company's allocation of the purchase price to the assets acquired and liabilities assumed as of the Luxoft acquisition date is as follows: (in millions) Fair Value Cash and cash equivalents $ 113 Accounts receivable 233 Other current assets 15 Total current assets 361 Property and equipment 31 Intangible assets 577 Other assets 99 Total assets acquired 1,068 Accounts payable, accrued payroll, accrued expenses, and other current liabilities (121) Deferred revenue (8) Long-term deferred tax liabilities and income tax payable (106) Other liabilities (72) Total liabilities assumed (307) Net identifiable assets acquired 761 Goodwill 1,262 Total consideration transferred $ 2,023 Goodwill represents the excess of the purchase price over the fair value of identifiable assets acquired and liabilities assumed at the acquisition date. The goodwill recognized with the acquisition was attributable to the synergies expected to be achieved by combining the businesses of DXC and Luxoft, expected future contracts and the acquired workforce. The cost-saving opportunities are expected to include improved operating efficiencies and asset optimization. The total goodwill arising from the acquisition was allocated to Global Business Services ("GBS") and is not deductible for tax purposes. The Company valued current assets and liabilities using existing carrying values as an estimate of the approximate fair value of those items at the acquisition date except for certain contract receivables for which the Company determined fair value based on a cost plus margin approach. The Company valued acquired property and equipment using predominately the direct capitalization method of the income approach and in certain specific cases, the Company determined that the net book value represents the fair value. The Company valued customer relationships using the multi-period excess earnings method under the income approach and valued trade names and developed technology using a relief from royalty method under the income approach. The Company determined that the net book value of the purchased software represents the fair value. Below are the estimated useful lives of the acquired intangibles: Estimated Useful Lives (Years) Customer related intangibles 10 Trade names 20 Developed technology 3 Third-party purchased software 3 The Company valued deferred tax liabilities based on statutory tax rates in the jurisdictions of the legal entities where the acquired non-current assets and liabilities are taxed. |
Divestitures
Divestitures | 9 Months Ended |
Dec. 31, 2020 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Divestitures | Divestitures HHS Sale On October 1, 2020, DXC completed the sale of its HHS Business to Veritas Capital. The sale was accomplished by the cash purchase of all equity interests and assets attributable to the HHS Business for a total enterprise value of $5.0 billion (including $85 million related to future services to be provided by the Company). As part of the sale of the HHS business, $272 million of repurchased receivables, previously sold under the Milano Receivables Facility ("Milano Facility') (see Note 6 - "Receivables" to the financial statements), $12 million of prepaid maintenance, and $48 million of software licenses transferred to the HHS Business. DXC made payment for these assets during the third quarter of fiscal 2021.The repurchase of receivables and payment on prepaid maintenance are reported as operating cash outflows, and the payment for software license is considered an investing cash outflow. The HHS Sale resulted in a pre-tax gain on sale of $2,041 million, net of closing costs. The sale price is subject to adjustment based on changes in actual closing net working capital. Final potential working capital adjustments are pending. The sale was not subject to any financing condition or shareholder approval. Approximately $3.5 billion of the sale proceeds were used to prepay $1,250 million of Revolver Credit Facility, £600 million of GBP commercial paper (approximately $772 million), and the following term loan facilities: €350 million of Euro Term Loan due fiscal 2024 (approximately $410 million), $381 million of USD Term loan due fiscal 2025, A$500 million of AUD Term Loan due fiscal 2022 (approximately $358 million), and €250 million of Euro Term Loan due fiscal 2022 and 2023 (approximately $292 million). See Note 12 - "Debt" to the financial statements. Following the transaction close, DXC retains its remaining healthcare practice, relating to the pending HPS sale. DXC's post-divesture relationship with the HHS Business is governed by the Purchase Agreement, which provides for the allocation of assets, employees, liabilities and obligations (including property, employee benefits, litigation, and tax-related assets and liabilities) between DXC and the HHS Business attributable to periods prior to, at and after divestment. In addition, DXC and the HHS Business have service and commercial contracts that generally extend through fiscal 2023. As of September 30, 2020, the divestment of the HHS Business, reported as part of the GBS segment, met the requirements for presentation as assets held for sale under GAAP. However, it did not meet the requirements for presentation as discontinued operations as it did not represent a strategic shift that would have a major effect on DXC's operations and financial results and is included in income from continuing operations for the nine months ended December 31, 2020 and 2019 prior to its sale closing date. The following is a summary of the assets and liabilities distributed as part of the HHS Sale on October 1, 2020: (in millions) Assets: Cash and cash equivalents $ 8 Accounts receivable, net 295 Prepaid expenses 39 Other current assets 2 Total current assets 344 Intangible assets, net 1,308 Operating right-of-use assets, net 74 Goodwill 1,354 Property and equipment, net 46 Other assets 54 Total non-current assets 2,836 Total assets $ 3,180 Liabilities: Accounts payable $ 79 Accrued payroll and related costs 13 Current operating lease liabilities 27 Accrued expenses and other current liabilities 36 Deferred revenue and advance contract payments 20 Total current liabilities 175 Non-current deferred revenue 32 Long-term operating lease liabilities 48 Other long term liabilities 2 Total long-term liabilities 82 Total liabilities $ 257 During the third quarter of fiscal 2021, the Company sold an insignificant business that resulted in a gain of $5 million. |
Earnings (Loss) per Share
Earnings (Loss) per Share | 9 Months Ended |
Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |
Earnings (Loss) per Share | Earnings (Loss) per Share Basic earnings per share ("EPS") is computed using the weighted average number of shares of common stock outstanding during the period. Diluted EPS reflects the incremental shares issuable upon the assumed exercise of stock options and equity awards. The following table reflects the calculation of basic and diluted EPS: Three Months Ended Nine Months Ended (in millions, except per-share amounts) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Net income (loss) attributable to DXC common shareholders: $ 1,098 $ 82 $ 649 $ (1,874) Common share information: Weighted average common shares outstanding for basic EPS 254.32 255.09 254.03 260.24 Dilutive effect of stock options and equity awards 1.43 0.96 1.17 — Weighted average common shares outstanding for diluted EPS 255.75 256.05 255.20 260.24 Earnings (loss) per share: Basic $ 4.32 $ 0.32 $ 2.55 $ (7.20) Diluted $ 4.29 $ 0.32 $ 2.54 $ (7.20) The following share-based equity awards were excluded from the computation of diluted EPS because inclusion of these awards would have had an anti-dilutive effect. The number of awards excluded were as follows: Three Months Ended Nine Months Ended December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Stock Options 1,519,611 621,028 1,582,568 818,490 Restricted Stock Units 1,418,752 2,125,734 1,628,968 2,116,898 Performance-based Restricted Stock Units 836,866 — 723,754 351,410 |
Receivables
Receivables | 9 Months Ended |
Dec. 31, 2020 | |
Receivables [Abstract] | |
Receivables | Receivables Receivables Facility The Company has an accounts receivable sales facility (as amended, restated, supplemented or otherwise modified as of December 31, 2020, the "Receivables Facility") with certain unaffiliated financial institutions (the "Purchasers") for the sale of commercial accounts receivable in the United States. Under the Receivables Facility, certain of the Company's subsidiaries (the "Sellers") sell accounts receivable to DXC Receivables LLC ("Receivables SPV"), a wholly owned bankruptcy-remote entity, in a true sale. Receivables SPV subsequently sells certain of the receivables in their entirety to the Purchasers pursuant to a receivables purchase agreement. The financial obligations of Receivables SPV to the Purchasers under the Receivables Facility are limited to the assets it owns and non-recourse to the Company. Sales of receivables by Receivables SPV occur continuously and are settled on a monthly basis. During the second quarter of fiscal 2021, Receivables SPV amended the Receivables Facility (the "Amendment") to decrease the facility limit from $600 million to $500 million and extend the termination date to August 5, 2021. For the nine months ended December 31, 2020, there is no deferred purchase price ("DPP") for receivables as the entire purchase price is paid in cash when the receivables are sold to the Purchasers. DPPs were previously realized by Receivables SPV upon the ultimate collection of the underlying receivables sold to the Purchasers. Cash receipts on the DPP were classified as cash flows from investing activities. The amount available under the Receivables Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business after deducting excess concentrations. As of December 31, 2020, the total availability under the Receivables Facility was $403 million, and the amount sold to the Purchasers was $407 million, which was derecognized from the Company's balance sheet. As of December 31, 2020, the Company recorded a $4 million liability within accounts payable because the amount of cash proceeds received by the Company under the Receivables Facility was more than the total availability. The Receivables Facility is scheduled to terminate on August 5, 2021, but provides for one or more optional one-year extensions, if agreed to by the Purchasers. The Company uses the proceeds from the sale of receivables under the Receivables Facility for general corporate purposes. The fair value of the sold receivables approximated book value due to the short-term nature, and as a result, no gain or loss on sale of receivables was recorded. While the Company guarantees certain non-financial performance obligations of the Sellers, the Purchasers bear customer credit risk associated with the receivables sold under the Receivables Facility and have recourse in the event of credit-related customer non-payment solely to the assets of the Receivables SPV. The following table is a reconciliation of the beginning and ending balance of the DPP for the Receivables Facility: (in millions) As of and for the Nine Months Ended December 31, 2019 Beginning balance $ 574 Transfers of receivables 1,214 Collections (1,265) Change in funding availability 2 Facility amendments (525) Ending balance $ — Milano Receivables Facility On October 1, 2020, and in connection with the consummation of the sale of the HHS Business, and at the direction of the purchaser of the HHS Business, the Milano Facility was terminated. For more information, refer to Note 4 - "Divestitures." German Receivables Facility On October 1, 2019, the Company executed an accounts receivable securitization facility (as amended, restated, supplemented or otherwise modified as of December 31, 2020, the "DE Receivables Facility") with certain unaffiliated financial institutions (the "DE Purchasers") for the sale of commercial accounts receivable in Germany. The DE Receivables Facility has a facility limit of €150 million (approximately $175 million as of December 31, 2020). Under the DE Receivables Facility, certain of the Company's subsidiaries organized in Germany (the "DE Sellers") sell accounts receivable to DXC ARFacility Designated Activity Company ("DE Receivables SPV"), a trust-owned bankruptcy-remote entity, in a true sale. DE Receivables SPV subsequently sells certain of the receivables in their entirety to the DE Purchasers pursuant to a receivables purchase agreement. Sales of receivables by DE Receivables SPV occur continuously and are settled on a monthly basis. During the first quarter of fiscal 2021, DE Receivables SPV amended the DE Receivables Facility ("DE Amendment"). Under the terms of the amended DE Receivables Facility, there is no longer any DPP for receivables as the entire purchase price is paid in cash when the receivables are sold to the DE Purchasers. Prior to the DE Amendment, DPPs were realized by DE Receivables SPV upon the ultimate collection of the underlying receivables sold to the DE Purchasers. Cash receipts on the DPPs were classified as cash flows from investing activities. The DPP balance was $102 million before the DE Amendment was executed. Upon execution of the DE Amendment, the DE Purchasers extinguished the DPP balance and returned title to the applicable underlying receivables to DE Receivables SPV. The DPP extinguishment was classified as a non-cash investing activity, please refer to Note 19 - "Cash Flows." The amount available under the DE Receivables Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business after deducting excess concentrations. As of December 31, 2020, the total availability under the DE Receivables Facility was approximately $123 million, and the amount sold to the DE Purchasers was $136 million, which was derecognized from the Company's balance sheet. As of December 31, 2020, the Company recorded a $13 million liability within accounts payable because the amount of cash proceeds received by the Company under the DE Receivables Facility was more than the total availability. The DE Receivables Facility is scheduled to terminate on September 30, 2021, but provides for one or more optional one-year extensions, if agreed to by the DE Purchasers. The Company uses the proceeds from DE Receivables SPV's sale of receivables under the DE Receivables Facility for general corporate purposes. The fair value of the sold receivables approximated book value due to the short-term nature, and as a result, no gain or loss on sale of receivables was recorded. Certain obligations of DE Sellers under the DE Receivables Facility and certain DXC subsidiaries located in Germany, as initial servicers, are guaranteed by the Company under a performance guaranty, made in favor of an administrative agent on behalf of the DE Purchasers. However, the performance guaranty does not cover DE Receivables SPV’s obligations to pay yield, fees or invested amounts to the administrative agent or any of the DE Purchasers. The following table is a reconciliation of the beginning and ending balances of the DPP for the DE Receivables Facility: (in millions) As of and for the Nine Months Ended December 31, 2020 Beginning balance $ 103 Transfers of receivables 417 Collections (420) Change in funding availability 2 Facility amendments (102) Ending balance $ — Allowance The Company calculates expected credit losses for trade accounts receivable based on historical credit loss rates for each aging category as adjusted for the current market conditions and forecasts about future economic conditions. The following table presents the activity in the allowance for doubtful accounts for trade accounts receivable: (in millions) As of and for the Nine Months Ended December 31, 2020 Beginning balance $ 74 Impact of adoption of the Credit Loss Standard 4 Provisions for losses on accounts receivable 52 Other adjustments to allowance and write-off's 69 Ending balance $ 199 |
Leases
Leases | 9 Months Ended |
Dec. 31, 2020 | |
Leases [Abstract] | |
Leases | Leases The Company has operating and finance leases for data centers, corporate offices, retail stores and certain equipment. Its leases have remaining lease terms of one one The components of lease expense were as follows: Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Operating lease cost $ 156 $ 166 $ 463 $ 506 Short-term lease cost 14 17 40 41 Variable lease cost 17 9 40 35 Sublease income (10) (9) (32) (28) Total operating costs $ 177 $ 183 $ 511 $ 554 Finance lease cost: Amortization of right-of-use assets $ 107 $ 90 $ 322 $ 339 Interest on lease liabilities 10 16 35 50 Total finance lease cost $ 117 $ 106 $ 357 $ 389 Cash payments made from variable lease costs and short-term leases are not included in the measurement of operating and finance lease liabilities, and as such, are excluded from the supplemental cash flow information stated below. In addition, for the supplemental non-cash information on operating and finance leases, please refer to Note 19 - "Cash Flows." Supplemental cash flow information related to leases was as follows: Nine Months Ended (in millions) December 31, 2020 December 31, 2019 Cash paid for amounts included in the measurement of: Operating cash flows used in operating leases $ 463 $ 506 Operating cash flows used in finance leases $ 35 $ 50 Financing cash flows used in finance leases $ 430 $ 436 Supplemental balance sheet information related to leases was as follows: As of (in millions) Balance Sheet Line Item December 31, 2020 March 31, 2020 Assets: ROU operating lease assets Operating right-of-use assets, net $ 1,459 $ 1,428 ROU finance lease assets Property and Equipment, net 971 1,220 Total $ 2,430 $ 2,648 Liabilities: Current Operating lease Current operating lease liabilities $ 450 $ 482 Finance lease Short-term debt and current maturities of long-term debt 431 444 Total $ 881 $ 926 Non-current Operating lease Non-current operating lease liabilities $ 1,113 $ 1,063 Finance lease Long-term debt, net of current maturities 545 602 Total $ 1,658 $ 1,665 The following table provides information on the weighted average remaining lease term and weighted average discount rate for operating and finance leases: As of December 31, 2020 March 31, 2020 Weighted Average remaining lease term: Years Operating leases 4.8 4.8 Finance leases 2.7 2.7 Weighted average remaining discount rate: Rate Operating leases 4.0 % 4.0 % Finance leases 3.8 % 6.4 % The following maturity analysis presents expected undiscounted cash payments for operating and finance leases on an annual basis as of December 31, 2020: Fiscal year Operating Leases (in millions) Real Estate Equipment Finance Leases Remainder of 2021 $ 117 $ 15 $ 128 2022 412 42 419 2023 337 24 275 2024 262 11 139 2025 192 5 48 Thereafter 297 3 6 Total lease payments 1,617 100 1,015 Less: imputed interest (151) (3) (39) Total payments $ 1,466 $ 97 $ 976 |
Leases | Leases The Company has operating and finance leases for data centers, corporate offices, retail stores and certain equipment. Its leases have remaining lease terms of one one The components of lease expense were as follows: Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Operating lease cost $ 156 $ 166 $ 463 $ 506 Short-term lease cost 14 17 40 41 Variable lease cost 17 9 40 35 Sublease income (10) (9) (32) (28) Total operating costs $ 177 $ 183 $ 511 $ 554 Finance lease cost: Amortization of right-of-use assets $ 107 $ 90 $ 322 $ 339 Interest on lease liabilities 10 16 35 50 Total finance lease cost $ 117 $ 106 $ 357 $ 389 Cash payments made from variable lease costs and short-term leases are not included in the measurement of operating and finance lease liabilities, and as such, are excluded from the supplemental cash flow information stated below. In addition, for the supplemental non-cash information on operating and finance leases, please refer to Note 19 - "Cash Flows." Supplemental cash flow information related to leases was as follows: Nine Months Ended (in millions) December 31, 2020 December 31, 2019 Cash paid for amounts included in the measurement of: Operating cash flows used in operating leases $ 463 $ 506 Operating cash flows used in finance leases $ 35 $ 50 Financing cash flows used in finance leases $ 430 $ 436 Supplemental balance sheet information related to leases was as follows: As of (in millions) Balance Sheet Line Item December 31, 2020 March 31, 2020 Assets: ROU operating lease assets Operating right-of-use assets, net $ 1,459 $ 1,428 ROU finance lease assets Property and Equipment, net 971 1,220 Total $ 2,430 $ 2,648 Liabilities: Current Operating lease Current operating lease liabilities $ 450 $ 482 Finance lease Short-term debt and current maturities of long-term debt 431 444 Total $ 881 $ 926 Non-current Operating lease Non-current operating lease liabilities $ 1,113 $ 1,063 Finance lease Long-term debt, net of current maturities 545 602 Total $ 1,658 $ 1,665 The following table provides information on the weighted average remaining lease term and weighted average discount rate for operating and finance leases: As of December 31, 2020 March 31, 2020 Weighted Average remaining lease term: Years Operating leases 4.8 4.8 Finance leases 2.7 2.7 Weighted average remaining discount rate: Rate Operating leases 4.0 % 4.0 % Finance leases 3.8 % 6.4 % The following maturity analysis presents expected undiscounted cash payments for operating and finance leases on an annual basis as of December 31, 2020: Fiscal year Operating Leases (in millions) Real Estate Equipment Finance Leases Remainder of 2021 $ 117 $ 15 $ 128 2022 412 42 419 2023 337 24 275 2024 262 11 139 2025 192 5 48 Thereafter 297 3 6 Total lease payments 1,617 100 1,015 Less: imputed interest (151) (3) (39) Total payments $ 1,466 $ 97 $ 976 |
Fair Value
Fair Value | 9 Months Ended |
Dec. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Fair Value | Fair Value Fair Value Measurements on a Recurring Basis The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis excluding pension assets and derivative assets and liabilities. See Note 9 - "Derivative and Hedging Activities" for information about the fair value of the Company's derivative assets and liabilities. There were no transfers among any of the levels during the periods presented. Fair Value Hierarchy (in millions) December 31, 2020 Assets: Fair Value Level 1 Level 2 Level 3 Money market funds and money market deposit accounts $ 262 $ 262 $ — $ — U.S. treasury bills (1) 250 250 — — Time deposits (1) 349 349 — — Other debt securities (2) 62 — 59 3 Total assets $ 923 $ 861 $ 59 $ 3 Liabilities: Contingent consideration $ 40 $ — $ — $ 40 Total liabilities $ 40 $ — $ — $ 40 March 31, 2020 Assets: Fair Value Level 1 Level 2 Level 3 Money market funds and money market deposit accounts $ 156 $ 156 $ — $ — Time deposits (1) 595 595 — — Other debt securities (2) 51 — 48 3 Deferred purchase price receivable 103 — — 103 Total assets $ 905 $ 751 $ 48 $ 106 Liabilities: Contingent consideration $ 46 $ — $ — $ 46 Total liabilities $ 46 $ — $ — $ 46 (1) Cost basis approximated fair value due to the short period of time to maturity. (2) Other debt securities include available-for-sale investments with Level 2 inputs with cost bases of $59 million and $37 million, and unrealized gains of $0 million and $11 million, as of December 31, 2020 and March 31, 2020, respectively. During the quarter, previously held investments were sold and the proceeds were used to purchase new investments. The gain of $17 million from the sale was included in other income, net. The fair value of money market funds, money market deposit accounts, U.S. Treasury bills with less than three months maturity and time deposits, included in cash and cash equivalents are based on quoted market prices. The fair value of other debt securities included in other long-term assets is based on actual market prices. The fair value of the DPPs included in receivables, net is determined by calculating the expected amount of cash to be received and is principally based on unobservable inputs consisting primarily of the face amount of the receivables adjusted for anticipated credit losses. The fair value of contingent consideration included in other liabilities is based on contractually defined targets of financial performance in connection with earn outs and other considerations. Other Fair Value Disclosures The carrying amounts of the Company’s financial instruments with short-term maturities, primarily accounts receivable, accounts payable, short-term debt, and financial liabilities included in other accrued liabilities are deemed to approximate their market values due to their short-term nature. If measured at fair value, these financial instruments would be classified as Level 2 or Level 3 within the fair value hierarchy. The Company estimates the fair value of its long-term debt primarily by using quoted prices obtained from third-party providers such as Bloomberg and by using an expected present value technique that is based on observable market inputs for instruments with similar terms currently available to the Company. The estimated fair value of the Company's long-term debt excluding finance lease liabilities was $5.5 billion and $8.2 billion as of December 31, 2020 and March 31, 2020, respectively as compared with carrying value of $5.2 billion and $8.4 billion as of December 31, 2020 and March 31, 2020, respectively. Long-term debt excluding finance lease liabilities is classified as Level 1 or Level 2 within the fair value hierarchy. Non-financial assets such as goodwill, tangible assets, intangible assets and other contract related long-lived assets are recorded at fair value in the period they are initially recognized, and such fair value may be adjusted in subsequent periods if an event occurs or circumstances change that indicate that the asset may be impaired. The fair value measurements in such instances would be classified as Level 3 within the fair value hierarchy. There were no significant impairments recorded during the fiscal period covered by this report. |
Derivative and Hedging Activiti
Derivative and Hedging Activities | 9 Months Ended |
Dec. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative and Hedging Activities | Derivative and Hedging Activities In the normal course of business, the Company is exposed to interest rate and foreign exchange rate fluctuations. As part of its risk management strategy, the Company uses derivative instruments, primarily foreign currency forward contracts and interest rate swaps, to hedge certain foreign currency and interest rate exposures. The Company’s objective is to reduce earnings volatility by offsetting gains and losses resulting from these exposures with losses and gains on the derivative contracts used to hedge them. The Company does not use derivative instruments for trading or any speculative purposes. Derivatives Designated for Hedge Accounting Cash flow hedges The Company has designated certain foreign currency forward contracts as cash flow hedges to reduce foreign currency risk related to certain Indian Rupee-denominated intercompany obligations and forecasted transactions. The notional amounts of foreign currency forward contracts designated as cash flow hedges as of December 31, 2020 and March 31, 2020 were $507 million and $455 million, respectively. As of December 31, 2020, the related forecasted transactions extend through March 2023. For the three and nine months ended December 31, 2020 and December 31, 2019, respectively, the Company performed an assessment at the inception of the cash flow hedge transactions and determined that all critical terms of the hedging instruments and hedged items matched. The Company performs an assessment of critical terms on an on-going basis throughout the hedging period. During the three and nine months ended December 31, 2020 and December 31, 2019, respectively, the Company had no cash flow hedges for which it was probable that the hedged transaction would not occur. As of December 31, 2020, $2 million of the existing amount of gain related to the cash flow hedge reported in accumulated other comprehensive loss is expected to be reclassified into earnings within the next 12 months. The pre-tax gain (loss) on derivatives designated for hedge accounting recognized in income from operation was $0 million and $(6) million for the three and nine months ended December 31, 2020, respectively. The pre-tax gain (loss) on derivatives designated for hedge accounting recognized in other comprehensive income was $0 million and $18 million for the three and nine months ended December 31, 2020, respectively. Derivatives Not Designated for Hedge Accounting The derivative instruments not designated as hedges for purposes of hedge accounting include certain short-term foreign currency forward contracts. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. Foreign currency forward contracts The Company manages the exposure to fluctuations in foreign currencies by using short-term foreign currency forward contracts to hedge certain foreign currency denominated assets and liabilities, including intercompany accounts and forecasted transactions. The notional amounts of the foreign currency forward contracts outstanding as of December 31, 2020 and March 31, 2020 were $1.7 billion and $2.2 billion, respectively. The following table presents the pretax amounts impacting income related to designated and non-designated foreign currency forward contracts: For the Three Months Ended For the Nine Months Ended (in millions) Statement of Operations Line Item December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Foreign currency forward contracts Other expense (income), net $ 16 $ 1 $ 74 $ (21) Fair Value of Derivative Instruments All derivative instruments are recorded at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. The following tables present the fair values of derivative instruments included in the balance sheets: Derivative Assets As of (in millions) Balance Sheet Line Item December 31, 2020 March 31, 2020 Derivatives designated for hedge accounting: Foreign currency forward contracts Other current assets $ 9 $ — Total fair value of derivatives designated for hedge accounting $ 9 $ — Derivatives not designated for hedge accounting: Foreign currency forward contracts Other current assets $ 6 $ 16 Total fair value of derivatives not designated for hedge accounting $ 6 $ 16 Derivative Liabilities As of (in millions) Balance Sheet Line Item December 31, 2020 March 31, 2020 Derivatives designated for hedge accounting: Foreign currency forward contracts Accrued expenses and other current liabilities $ 5 $ 20 Total fair value of derivatives designated for hedge accounting: $ 5 $ 20 Derivatives not designated for hedge accounting: Foreign currency forward contracts Accrued expenses and other current liabilities $ 17 $ 12 Total fair value of derivatives not designated for hedge accounting $ 17 $ 12 The fair value of foreign currency forward contracts represents the estimated amount required to settle the contracts using current market exchange rates and is based on the period-end foreign currency exchange rates and forward points which are classified as Level 2 inputs. Other Risks for Derivative Instruments The Company is exposed to the risk of losses in the event of non-performance by the counterparties to its derivative contracts. The amount subject to credit risk related to derivative instruments is generally limited to the amount, if any, by which a counterparty's obligations exceed the obligations of the Company with that counterparty. To mitigate counterparty credit risk, the Company regularly reviews its credit exposure and the creditworthiness of the counterparties. With respect to its foreign currency derivatives, as of December 31, 2020, there were seven counterparties with concentration of credit risk, and based on gross fair value, the maximum amount of loss that the Company could incur is not material. The Company also enters into enforceable master netting arrangements with some of its counterparties. However, for financial reporting purposes, it is the Company's policy not to offset derivative assets and liabilities despite the existence of enforceable master netting arrangements. The potential effect of such netting arrangements on the Company's balance sheets is not material for the periods presented. Non-Derivative Financial Instruments Designated for Hedge Accounting The Company applies hedge accounting for foreign currency-denominated debt used to manage foreign currency exposures on its net investments in certain non-U.S. operations. To qualify for hedge accounting, the hedging instrument must be highly effective at reducing the risk from the exposure being hedged. Net Investment Hedges DXC seeks to reduce the impact of fluctuations in foreign exchange rates on its net investments in certain non-U.S. operations with foreign currency-denominated debt. For foreign currency-denominated debt designated as a hedge, the effectiveness of the hedge is assessed based on changes in spot rates. For qualifying net investment hedges, all gains or losses on the hedging instruments are included in currency translation. Gains or losses on individual net investments in non-U.S. operations are reclassified to earnings from accumulated other comprehensive income when such net investments are sold or substantially liquidated. |
Intangible Assets
Intangible Assets | 9 Months Ended |
Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets | Intangible Assets Intangible assets consisted of the following: As of December 31, 2020 (in millions) Gross Carrying Value Accumulated Amortization Net Carrying Value Software $ 4,001 $ 2,891 $ 1,110 Customer related intangible assets 4,296 1,606 2,690 Other intangible assets 267 48 219 Total intangible assets $ 8,564 $ 4,545 $ 4,019 As of March 31, 2020 (in millions) Gross Carrying Value Accumulated Amortization Net Carrying Value Software $ 4,048 $ 2,614 $ 1,434 Customer related intangible assets 5,795 1,697 4,098 Other intangible assets 235 36 199 Total intangible assets $ 10,078 $ 4,347 $ 5,731 The components of amortization expense were as follows: Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Intangible asset amortization $ 224 $ 272 $ 735 $ 747 Transition and transformation contract cost amortization (1) 66 71 194 197 Total amortization expense $ 290 $ 343 $ 929 $ 944 (1) Transition and transformation contract costs are included within other assets on the balance sheet. Estimated future amortization related to intangible assets as of December 31, 2020 is as follows: Fiscal Year (in millions) Remainder of 2021 $ 236 2022 $ 821 2023 $ 740 2024 $ 650 2025 $ 535 |
Goodwill
Goodwill | 9 Months Ended |
Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill | Goodwill The following table summarizes the changes in the carrying amount of goodwill, by segment, as of December 31, 2020. (in millions) GBS GIS Total Goodwill, gross $ 6,507 $ 5,066 $ 11,573 Accumulated impairment losses (4,490) (5,066) (9,556) Balance as of March 31, 2020, net $ 2,017 $ — $ 2,017 Acquisition related adjustments 18 — 18 Divestitures (1,355) — (1,355) Assets held for sale (4) — (4) Foreign currency translation 60 — 60 Goodwill, gross 5,226 5,066 10,292 Accumulated impairment losses (4,490) (5,066) (9,556) Balance as of December 31, 2020, net $ 736 $ — $ 736 The foreign currency translation amount reflects the impact of currency movements on non-U.S. dollar-denominated goodwill balances. Goodwill Impairment Analyses The Company tests goodwill for impairment on an annual basis, as of the first day of the second fiscal quarter, and between annual tests if circumstances change, or if an event occurs that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company's annual goodwill impairment analysis, which was performed qualitatively during the three months ended September 30, 2020, did not result in an impairment charge. At the end of the third quarter of fiscal 2021, the Company assessed whether there were events or changes in circumstances that would more likely than not reduce the fair value of its GBS reporting unit below its carrying amount and require goodwill to be tested for impairment. The Company determined that there have been no such indicators and therefore, it was unnecessary to perform an interim goodwill impairment test as of December 31, 2020. |
Debt
Debt | 9 Months Ended |
Dec. 31, 2020 | |
Debt Disclosure [Abstract] | |
Debt | Debt The following is a summary of the Company's debt: (in millions) Interest Rates Fiscal Year Maturities December 31, 2020 March 31, 2020 Short-term debt and current maturities of long-term debt Commercial paper (1) (0.22)% - 0.44% 2021 - 2022 $ 112 $ 542 Current maturities of long-term debt Various 2021 - 2022 252 290 Current maturities of finance lease liabilities 0.62% - 18.47% 2021 - 2022 431 444 Short-term debt and current maturities of long-term debt $ 795 $ 1,276 Long-term debt, net of current maturities AUD term loan 0.94% - 0.96% 2022 — 489 GBP term loan 0.88% - 1.46% 2022 — 556 EUR term loan 0.65% 2022 - 2023 — 822 EUR term loan 0.80% (2) 2023 - 2024 488 821 USD term loan 1.40% - 2.24% 2025 — 480 $274 million Senior notes 4.45% 2023 276 276 $171 million Senior notes 4.45% 2023 172 172 $500 million Senior notes 4.25% 2025 504 505 $500 million Senior notes 4.00% 2024 497 — $500 million Senior notes 4.13% 2026 496 — £250 million Senior notes 2.75% 2025 339 307 €650 million Senior notes 1.75% 2026 792 709 $500 million Senior notes 4.75% 2028 507 507 $234 million Senior notes 7.45% 2030 269 271 Revolving credit facility 1.26% - 2.08% 2024 - 2025 — 1,500 Lease credit facility 1.15% - 1.99% 2021 - 2023 — 11 Finance lease liabilities 0.62% - 18.47% 2021 - 2027 976 1,046 Borrowings for assets acquired under long-term financing 0.00% - 6.39% 2021 - 2027 742 802 Mandatorily redeemable preferred stock outstanding 6.00% 2023 63 62 Other borrowings Various 2021 - 2022 6 70 Long-term debt 6,127 9,406 Less: current maturities 683 734 Long-term debt, net of current maturities $ 5,444 $ 8,672 (1) At DXC's option, DXC can borrow up to a maximum of €1 billion or its equivalent in €, £, and $. (2) At DXC's option, the EUR term loan bears interest at the Eurocurrency Rate for a one-, two-, three-, or six-month interest period, plus a margin between 0.55% and 1.05%, based on published credit ratings of DXC. Senior Notes and Term Loans During the first quarter of fiscal 2021, the Company issued two senior notes with an aggregate principal of $1.0 billion consisting of (i) $500 million of 4.00% Senior Notes due fiscal 2024 and (ii) $500 million of 4.13% Senior Notes due fiscal 2026. The proceeds from these notes were applied towards the early prepayment of DXC's term loan facilities including prepayment of €500 million of Euro Term Loan due fiscal 2023, £150 million of GBP Term Loan due fiscal 2022, A$300 million of AUD Term Loan due fiscal 2022, and $100 million of USD Term Loan due fiscal 2025. During the second quarter of fiscal 2021, the Company repaid the remaining £300 million GBP Term Loan due fiscal 2022. During the third quarter of fiscal 2021, the Company used the proceeds from the sale of HHS Business to prepay approximately $1,441 million of term loan facilities detailed below under the heading "HHS Sale Use of Proceeds." Interest on the Company's remaining term loan is payable monthly at DXC's election. The Company fully and unconditionally guarantees term loans issued by its 100% owned subsidiaries. The interest on the Company's senior notes is payable semi-annually in arrears except for interest on the £250 million Senior Notes due fiscal 2025 and the €650 million Senior Notes due fiscal 2026, which are payable annually in arrears. Generally, the Company's notes are redeemable at the Company's discretion at the then-applicable redemption premium plus accrued and unpaid interest. Revolving Credit Facility During fiscal 2021, the Company borrowed the remaining $2.5 billion under the $4.0 billion credit facility agreement ("Credit Agreement") as a precautionary measure to increase its cash position and increase financial flexibility in light of continuing uncertainty in the global economy and financial capital markets resulting from COVID-19. The Company repaid the full $4.0 billion during the first nine months of fiscal 2021, which became available under the revolving credit facility for redraw at the request of the Company. HHS Sale Use of Proceeds In October 2020, DXC sold the HHS business and used approximately $3.5 billion of the proceeds to prepay $1,250 million of Revolver Credit Facility, £600 million of GBP commercial paper (approximately $772 million), and the following term loan facilities: €350 million of Euro Term Loan due fiscal 2024 (approximately $410 million), $381 million of USD Term loan due fiscal 2025, A$500 million of AUD Term Loan due fiscal 2022 (approximately $358 million), and €250 million of Euro Term Loan due fiscal 2022 and 2023 (approximately $292 million). |
Revenue
Revenue | 9 Months Ended |
Dec. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Revenue Recognition The following table presents DXC's revenues disaggregated by geography, based on the location of incorporation of the DXC entity providing the related goods or services: Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 United States $ 1,290 $ 1,843 $ 4,665 $ 5,500 United Kingdom 607 707 1,759 2,100 Other Europe 1,335 1,329 3,784 3,819 Australia 377 380 1,128 1,119 Other International 679 762 2,008 2,224 Total Revenues $ 4,288 $ 5,021 $ 13,344 $ 14,762 The revenue by geography pertains to both of the Company’s reportable segments. Refer to Note 20 - "Segment Information" for the Company’s segment disclosures. Remaining Performance Obligations Remaining performance obligations represent the aggregate amount of the transaction price in contracts allocated to performance obligations not delivered, or partially undelivered, as of the end of the reporting period. Remaining performance obligation estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue that have not materialized and adjustments for currency. As of December 31, 2020, approximately $24 billion of revenue is expected to be recognized from remaining performance obligations. We expect to recognize revenue on approximately 14% of these remaining performance obligations in fiscal 2021, with the remainder of the balance recognized thereafter. Contract Balances The following table provides information about the balances of the Company's trade receivables and contract assets and contract liabilities: As of (in millions) December 31, 2020 March 31, 2020 Trade receivables, net $ 2,785 $ 3,059 Contract assets $ 418 $ 454 Contract liabilities $ 1,768 $ 1,756 Change in contract liabilities were as follows: Nine Months Ended (in millions) December 31, 2020 (1) December 31, 2019 Balance, beginning of period $ 1,756 $ 1,886 Deferred revenue 2,111 2,091 Recognition of deferred revenue (2,137) (2,137) Currency translation adjustment 146 12 Other (108) (36) Balance, end of period $ 1,768 $ 1,816 |
Restructuring Costs
Restructuring Costs | 9 Months Ended |
Dec. 31, 2020 | |
Restructuring Costs [Abstract] | |
Restructuring Costs | Restructuring Costs The Company recorded restructuring costs of $104 million and $74 million, net of reversals, for the three months ended December 31, 2020 and December 31, 2019, respectively. For the nine months ended December 31, 2020 and December 31, 2019, the Company recorded restructuring costs of $441 million and $248 million, net of reversals, respectively. The costs recorded during the three and six months ended December 31, 2020 were largely a result of the Fiscal 2021 Plan (defined below). The composition of restructuring liabilities by financial statement line item is as follows: As of (in millions) December 31, 2020 Accrued expenses and other current liabilities $ 261 Other long-term liabilities 60 Total $ 321 Summary of Restructuring Plans Fiscal 2021 Plan During fiscal 2021, management approved global cost savings initiatives designed to better align the Company's workforce and facility structures (the "Fiscal 2021 Plan"). Fiscal 2020 Plan During fiscal 2020, management approved cost savings initiatives designed to reduce operating costs by re-balancing its workforce and facilities structures (the "Fiscal 2020 Plan"). The Fiscal 2020 Plan includes workforce optimization programs and facilities and data center rationalization. Costs incurred to date under the Fiscal 2020 Plan total $295 million, comprising $278 million in employee severance and $17 million of facilities costs. Fiscal 2019 Plan During fiscal 2019, management approved global cost savings initiatives designed to better align the Company's organizational structure with its strategic initiatives and continue the integration of the Enterprise Services business of Hewlett Packard Enterprise Company ("HPES") and other acquisitions (the "Fiscal 2019 Plan"). The Fiscal 2019 Plan includes workforce optimization and rationalization of facilities and data center assets. Costs incurred to date under the Fiscal 2019 Plan total $477 million, comprising $336 million in employee severance and $141 million of facilities costs. Other Prior Year Plans In June 2017, management approved a post-HPES Merger (as defined below) restructuring plan to optimize the Company's operations in response to a continuing business contraction (the "Fiscal 2018 Plan"). The Fiscal 2018 Plan focuses mainly on optimizing specific aspects of global workforce, increasing the proportion of work performed in low cost offshore locations and re-balancing the organizational structure. Additionally, this plan included global facility restructuring, including a global data center restructuring program. Costs incurred to date under the Fiscal 2018 Plan total $987 million, comprising $791 million in employee severance and $196 million of facilities costs. Acquired Restructuring Liabilities As a result of the merger of Computer Sciences Corporation ("CSC") and HPES ("HPES Merger"), DXC acquired restructuring liabilities under restructuring plans that were initiated for HPES under plans approved by the HPE Board of Directors. Restructuring Liability Reconciliations by Plan Restructuring Liability as of March 31, 2020 Costs Expensed, Net of Reversals (1) Costs Not Affecting Restructuring Liability (2) Cash Paid Other (3) Restructuring Liability as of December 31, 2020 Fiscal 2021 Plan Workforce Reductions $ — $ 416 $ (9) $ (210) $ 9 $ 206 Facilities Costs — 25 (9) (11) (1) 4 Total $ — $ 441 $ (18) $ (221) $ 8 $ 210 Fiscal 2020 Plan Workforce Reductions (4) $ 74 $ 7 $ 2 $ (49) $ 5 $ 39 Facilities Costs 2 (4) 4 (2) — — Total $ 76 $ 3 $ 6 $ (51) $ 5 $ 39 Fiscal 2019 Plan Workforce Reductions $ 25 $ (2) $ (3) $ (13) $ 2 $ 9 Facilities Costs 5 (3) 2 — 1 5 Total $ 30 $ (5) $ (1) $ (13) $ 3 $ 14 Other Prior Year Plans Workforce Reductions $ 24 $ 1 $ 2 $ (14) $ 2 $ 15 Facilities Costs — — — — — — Total $ 24 $ 1 $ 2 $ (14) $ 2 $ 15 Acquired Liabilities Workforce Reductions $ 39 $ 1 $ — $ (7) $ 1 $ 34 Facilities Costs 11 — 1 (3) — 9 Total $ 50 $ 1 $ 1 $ (10) $ 1 $ 43 (1) Costs expensed, net of reversals include $11 million, $10 million, and $3 million of costs reversed from the Fiscal 2020 Plan, Fiscal 2019 Plan and Other Prior Year Plans, respectively. (2) Costs Not Affecting Restructuring Liability include pension benefit augmentations recorded as a pension liability, asset impairments and restructuring costs associated with right-of-use assets. (3) Other include foreign currency translation adjustments. (4) Fiscal 2020 workforce reductions includes a $14 million adjustment to restructuring expense related to the prior year. |
Pension and Other Benefit Plans
Pension and Other Benefit Plans | 9 Months Ended |
Dec. 31, 2020 | |
Retirement Benefits [Abstract] | |
Pension and Other Benefit Plans | Pension and Other Benefit Plans The Company offers a number of pension and other post-retirement benefit ("OPEB") plans, life insurance benefits, deferred compensation and defined contribution plans. Most of the Company's pension plans are not admitting new participants, except where locally required; therefore, changes to pension liabilities are primarily due to market fluctuations of investments for existing participants and changes in interest rates. Defined Benefit Plans The Company sponsors a number of defined benefit and post-retirement medical benefit plans for the benefit of eligible employees. The benefit obligations of the Company's U.S. pension, U.S. OPEB, and non-U.S. OPEB represent an insignificant portion of the Company's pension and other post-retirement benefits. As a result, the disclosures below include the Company's U.S. and non-U.S. pension plans on a global consolidated basis. During the three months ended June 30, 2020, the Company remeasured plan assets and liabilities as of June 1, 2020 under certain U.K. pension plans due to the end of a public sector contract. The remeasurement resulted in a net loss of $2 million, comprising a curtailment gain of $9 million and an actuarial loss of $11 million. The net loss was recognized within other income. The components of net periodic pension income were: Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Service cost $ 23 $ 23 $ 68 $ 69 Interest cost 62 60 181 177 Expected return on assets (163) (161) (477) (476) Amortization of prior service costs (2) (2) (6) (6) Contractual termination benefit — — 3 17 Curtailment gain — — (9) — Recognition of actuarial loss — — 11 — Net periodic pension income $ (80) $ (80) $ (229) $ (219) The service cost component of net periodic pension income is presented in costs of services and selling, general and administrative and the other components of net periodic pension income are presented in other income, net, except for contractual termination benefit which is included in restructuring, in the Company’s statements of operations. Deferred Compensation Plans Effective as of the HPES Merger, DXC assumed sponsorship of the Computer Sciences Corporation Deferred Compensation Plan, which was renamed the “DXC Technology Company Deferred Compensation Plan” (the “DXC DCP”) and adopted HPE's Enterprise Services Executive Deferred Compensation Plan (the “ES DCP”). Both plans are non-qualified deferred compensation plans maintained for a select group of management, highly compensated employees and non-employee directors. The DXC DCP covers eligible employees who participated in CSC’s Deferred Compensation Plan prior to the HPES Merger. The ES DCP covers eligible employees who participated in the HPE Executive Deferred Compensation Plan prior to the HPES Merger. Both plans allow participating employees to defer the receipt of current compensation to a future distribution date or event above the amounts that may be deferred under DXC’s tax-qualified 401(k) plan, the DXC Technology Matched Asset Plan. Neither plan provides for employer contributions. As of April 3, 2017, the ES DCP does not admit new participants. Certain management and highly compensated employees are eligible to defer all, or a portion of, their regular salary that exceeds the limitation set forth in Internal Revenue Section 401(a)(17) and all or a portion of their incentive compensation. Non-employee directors are eligible to defer up to 100% of their cash compensation. The liability, which is included in other long-term liabilities in the Company's balance sheets, amounted to $45 million as of December 31, 2020 and $48 million as of March 31, 2020. |
Income Taxes
Income Taxes | 9 Months Ended |
Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company's effective tax rate ("ETR") was 44.2% and 29.1% for the three months ended December 31, 2020 and December 31, 2019, respectively, and 54.5% and (11.5)% for the nine months ended December 31, 2020 and December 31, 2019, respectively. For the three and nine months ended December 31, 2020, the primary drivers of the ETR were the gain on sale of HHS Business, global mix of income and foreign tax credits. For the three months ended December 31, 2019, the primary drivers of the ETR were the impact of previously unrecognized tax effects on the tax deductible goodwill impaired during the fiscal 2020 second quarter, the global mix of income, an increase in prior year U.S. federal research and development income tax credits, and an increase in unrecognized tax benefits primarily related to audit activity. For the nine months ended December 31, 2019, the primary drivers of the ETR were the impact of the non-deductible goodwill impairment charge, the non-taxable gain on the arbitration award, the global mix of income, an increase in unrecognized tax benefits primarily related to audit activity, and an increase in prior year U.S. federal research and development income tax credits, net. The majority of unremitted foreign earnings have been taxed in the U.S. We expect a significant portion of the unremitted earnings of our foreign subsidiaries will no longer be subject to U.S. federal income tax upon repatriation to the U.S. However, a portion of these earnings may still be subject to foreign and U.S. state tax consequences when remitted. Earnings in India are indefinitely reinvested. Other foreign earnings are not indefinitely reinvested except for approximately $547 million that could be taxable when repatriated to the U.S. under Treasury regulations that were issued during the first quarter of fiscal 2020. In connection with the HPES Merger, the Company entered into a tax matters agreement with HPE. HPE generally will be responsible for pre-HPES Merger tax liabilities including adjustments made by tax authorities to HPES U.S. and non-U.S. income tax returns. Likewise, DXC is liable to HPE for income tax receivables and refunds which it receives related to pre-HPES Merger periods. Pursuant to the tax matters agreement, the Company recorded a net payable of $3 million due to $48 million of tax indemnification receivable related to uncertain tax positions net of related deferred tax benefits, $79 million of tax indemnification receivable related to other tax payables and $130 million of tax indemnification payable related to other tax receivables. In connection with the USPS Separation, the Company entered into a tax matters agreement with Perspecta. Pursuant to the tax matters agreement, the Company generally will be responsible for tax liabilities arising prior to the USPS Separation. Income tax liabilities transferred to Perspecta primarily relate to pre-HPES Merger periods, for which the Company is indemnified by HPE pursuant to the tax matters agreement between the Company and HPE. The Company remains liable to HPE for tax receivables and refunds which it receives from Perspecta related to pre-HPES Merger periods that were transferred to Perspecta. Pursuant to the tax matters agreement, the Company has recorded a tax indemnification receivable from Perspecta of $81 million and a tax indemnification payable to Perspecta of $44 million related to income tax and other tax liabilities. The IRS is examining the Company's federal income tax returns for fiscal 2008 through the tax year ended October 31, 2018. With respect to CSC's fiscal 2008 through 2017 federal tax returns, the Company has entered into negotiations for a resolution on the years under audit through settlement with the IRS Office of Appeals. The IRS examined several issues for these years that resulted in various audit adjustments. The Company and the IRS Office of Appeals have an agreement in principle as to some of these adjustments, and we disagree with the IRS’ disallowance of certain losses and deductions resulting from restructuring costs and tax planning strategies in previous years. These matters present a potential federal and state tax cost of $410 million (excluding interest and penalties), in addition to other disagreed issues. We expect two years of these audits (fiscal 2010 and fiscal 2013) to proceed to Tax Court. We believe we will ultimately prevail on the technical merits of these issues. The Company has agreed to extend the statute of limitations for fiscal years 2008 through 2012 through August 31, 2021, and for fiscal year 2013 through March 31, 2021 to provide for IRS completion of their review. The Company has agreed to extend the statute of limitations for fiscal years 2014 through fiscal 2017 through October 31, 2021 to provide for IRS completion of their review. The Company expects to reach a resolution for all years no earlier than the fourth quarter of fiscal 2022 except agreed issues related to fiscal 2008 through 2010 federal tax returns, which are expected to be resolved within twelve months. In addition, the Company may settle certain other tax examinations, have lapses in statutes of limitations, or voluntarily settle income tax positions in negotiated settlements for different amounts than the Company has accrued as uncertain tax positions. In the third quarter of fiscal 2021 the Company’s liability for uncertain tax positions decreased by $13 million (excluding interest and penalties and related tax attributes) primarily due to an audit settlement. The Company may need to accrue and ultimately pay additional amounts for tax positions that previously met a more-likely-than-not standard if such positions are not upheld. Conversely, the Company could settle positions by payment with the tax authorities for amounts lower than those that have been accrued or extinguish a position through less payment than previously estimated. The Company believes that the outcomes that are reasonably possible within the next 12 months may result in a reduction in liability for uncertain tax positions of $37 million, excluding interest, penalties and tax carry-forwards. |
Stockholders' Equity
Stockholders' Equity | 9 Months Ended |
Dec. 31, 2020 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders' Equity Share Repurchases On April 3, 2017, DXC announced the establishment of a share repurchase program approved by the Board of Directors with an initial authorization of $2.0 billion for future repurchases of outstanding shares of DXC common stock. On November 8, 2018, DXC's Board of Directors approved an incremental $2.0 billion share repurchase authorization. An expiration date has not been established for this repurchase plan. Share repurchases may be made from time to time through various means, including in open market purchases, 10b5-1 plans, privately-negotiated transactions, accelerated stock repurchases, block trades and other transactions, in compliance with Rule 10b-18 under the Exchange Act as well as, to the extent applicable, other federal and state securities laws and other legal requirements. The timing, volume, and nature of share repurchases pursuant to the share repurchase plan are at the discretion of management and may be suspended or discontinued at any time. The shares repurchased are retired immediately and included in the category of authorized but unissued shares. The excess of purchase price over par value of the common shares is allocated between additional paid-in capital and retained earnings. There was no share repurchase activity during the nine months ended December 31, 2020. The details of shares repurchased during the nine months ended December 31, 2019 are shown below: Fiscal 2020 Fiscal Period Number of Shares Repurchased Average Price Per Share Amount (in millions) 1st Quarter Open market purchases 5,510,415 $ 54.44 $ 300 Accelerated stock repurchases 1,849,194 $ 54.08 100 1st Quarter Total 7,359,609 $ 54.35 400 2nd Quarter Open market purchases 4,414,840 $ 33.96 150 Accelerated stock repurchases 1,805,350 $ 55.39 100 2nd Quarter Total 6,220,190 $ 40.18 250 3rd Quarter Open market purchases 2,353,852 $ 36.68 86 Accelerated stock repurchases — $ — — 3rd Quarter Total 2,353,852 $ 36.68 86 Total 15,933,651 $ 46.21 $ 736 Accumulated Other Comprehensive Loss The following table shows the changes in accumulated other comprehensive income (loss), net of taxes: (in millions) Foreign Currency Translation Adjustments Cash Flow Hedges Available-for-sale Securities Pension and Other Post-retirement Benefit Plans Accumulated Other Comprehensive Loss Balance at March 31, 2020 $ (851) $ (20) $ 9 $ 259 $ (603) Current-period other comprehensive income 197 12 (6) — 203 Amounts reclassified from accumulated other comprehensive loss — 6 — (13) (7) Balance at December 31, 2020 $ (654) $ (2) $ 3 $ 246 $ (407) (in millions) Foreign Currency Translation Adjustments Cash Flow Hedges Available-for-sale Securities Pension and Other Post-retirement Benefit Plans Accumulated Other Comprehensive Loss Balance at March 31, 2019 $ (517) $ (3) $ 9 $ 267 $ (244) Current-period other comprehensive loss 78 (4) 2 — 76 Amounts reclassified from accumulated other comprehensive income (loss) — (2) — (6) (8) Balance at December 31, 2019 $ (439) $ (9) $ 11 $ 261 $ (176) |
Stock Incentive Plans
Stock Incentive Plans | 9 Months Ended |
Dec. 31, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Stock Incentive Plans | Stock Incentive Plans Equity Plans The Compensation Committee of the Board of Directors (the "Board") has broad authority to grant awards and otherwise administer the DXC Employee Equity Plan. The plan became effective March 30, 2017 and will continue in effect for a period of 10 years thereafter, unless earlier terminated by the Board. The Board has the authority to amend the plan in such respects as it deems desirable, subject to approval of DXC’s stockholders for material modifications. Restricted stock units ("RSUs") represent the right to receive one share of DXC common stock upon a future settlement date, subject to vesting and other terms and conditions of the award, plus any dividend equivalents accrued during the award period. In general, if the employee’s status as a full-time employee is terminated prior to the vesting of the RSU grant in full, then the RSU grant is automatically canceled on the termination date and any unvested shares and dividend equivalents are forfeited. Certain executives were awarded service-based "career share" RSUs for which the shares are settled over the 10 anniversaries following the executive's separation from service as a full-time employee, provided the executive complies with certain non-competition covenants during that period. The Company also grants Performance-based restricted stock units ("PSUs"), which generally vest over a period of three years. The number of PSUs that ultimately vest is dependent upon the Company’s achievement of certain specified financial performance criteria over a three-year period. If the specified performance criteria are met, awards are settled for shares of DXC common stock and dividend equivalents upon the filing with the SEC of the Annual Report on Form 10-K for the last fiscal year of the performance period. PSU awards include the potential for up to 25% of the shares granted to be earned after the first and second fiscal years if certain of the Company's performance targets are met early, subject to vesting based on the participant's continued employment through the end of the three-year performance period. In fiscal 2021, DXC issued awards that are considered to have a market condition. A Monte Carlo simulation model was used for the valuation of the grants. Settlement of shares for the fiscal 2021 PSU awards will be made at the end of the third fiscal year subject to certain compounded annual growth rates of the stock price and continued employment through the last day of the third fiscal year. The terms of the DXC Director Equity Plan allow DXC to grant RSU awards to non-employee directors of DXC. Such RSU awards vest in full at the earlier of (i) the first anniversary of the grant date or (ii) the next annual meeting date, and are automatically redeemed for DXC common stock and dividend equivalents either at that time or, if an RSU deferral election form is submitted, upon the date or event elected by the director. Distributions made upon a director’s separation from the Board may occur in either a lump sum or in annual installments over periods of 5, 10, or 15 years, per the director’s election. In addition, RSUs vest in full upon a change in control of DXC. The DXC Share Purchase Plan allows DXC’s employees located in the United Kingdom to purchase shares of DXC’s common stock at the fair market value of such shares on the applicable purchase date. There were 12,232 and 41,425 shares purchased under this plan during the three and nine months ended December 31, 2020. The Board has reserved for issuance shares of DXC common stock, par value $0.01 per share, under each of the plans as detailed below: As of December 31, 2020 Reserved for Issuance Available for Future Grants DXC Employee Equity Plan 51,200,000 32,794,274 DXC Director Equity Plan 745,000 435,951 DXC Share Purchase Plan 250,000 165,185 Total 52,195,000 33,395,410 Stock Options Number of Option Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (in millions) Outstanding as of March 31, 2020 1,869,815 $ 29.92 4.27 $ — Granted — $ — Exercised (39,601) $ 17.43 $ — Canceled/Forfeited — $ — Expired (82,614) $ 31.24 Outstanding as of December 31, 2020 1,747,600 $ 30.11 3.73 $ 3 Vested and exercisable as of December 31, 2020 1,747,600 $ 30.11 3.73 $ 3 Restricted Stocks Employee Equity Plan Director Equity Plan Number of Weighted Number of Weighted Average Grant Date Fair Value Outstanding as of March 31, 2020 4,174,476 $ 55.45 114,615 $ 37.69 Granted 7,576,602 $ 18.67 118,500 $ 18.82 Settled (1,045,190) $ 50.65 (48,455) $ 26.90 Canceled/Forfeited (2,042,804) $ 36.14 — $ — Outstanding as of December 31, 2020 8,663,084 $ 28.43 184,660 $ 28.42 Share-Based Compensation Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Total share-based compensation cost $ 6 $ 9 $ 42 $ 57 Related income tax benefit $ 2 $ (3) $ 7 $ 8 Total intrinsic value of options exercised $ — $ 1 $ — $ 8 Tax benefits from exercised stock options and awards $ 1 $ 3 $ 5 $ 13 As of December 31, 2020, total unrecognized compensation expense related to unvested DXC stock options and unvested DXC RSUs, net of expected forfeitures was $0 million and $146 million, respectively. The unrecognized compensation expense for unvested RSUs is expected to be recognized over a weighted-average period of 2.06 years. |
Cash Flows
Cash Flows | 9 Months Ended |
Dec. 31, 2020 | |
Supplemental Cash Flow Elements [Abstract] | |
Cash Flows | Cash Flows Cash payments for interest on indebtedness and income taxes and other select non-cash activities are as follows: Nine Months Ended (in millions) December 31, 2020 December 31, 2019 Cash paid for: Interest $ 262 $ 277 Taxes on income, net of refunds (1) $ 159 $ 202 Non-cash activities: Operating: ROU assets obtained in exchange for lease, net (2) $ 449 $ 314 Prepaid assets acquired under long-term financing $ 46 $ 23 Investing: Capital expenditures in accounts payable and accrued expenses $ 16 $ 121 Capital expenditures through finance lease obligations $ 277 $ 507 Assets acquired under long-term financing $ 26 $ 282 (Decrease) increase in deferred purchase price receivable $ (52) $ 58 Contingent consideration $ 2 $ 19 Financing: Dividends declared but not yet paid $ — $ 54 (1) Income tax refunds were $31 million and $36 million for the nine months ended December 31, 2020 and December 31, 2019, respectively. (2) Net of $87 million change in lease classification from operating to finance lease in fiscal 2020. |
Segment Information
Segment Information | 9 Months Ended |
Dec. 31, 2020 | |
Segment Reporting [Abstract] | |
Segment Information | Segment Information DXC has a matrix form of organization and is managed in several different and overlapping groupings including services, industries and geographic regions. As a result, and in accordance with accounting standards, operating segments are organized by the type of services provided. DXC's chief operating decision maker ("CODM"), the chief executive officer, obtains, reviews, and manages the Company’s financial performance based on these segments. The CODM uses these results, in part, to evaluate the performance of, and allocate resources to, each of the segments. Global Business Services ("GBS") GBS provides innovative technology solutions that help its customers address key business challenges and accelerate digital transformations tailored to each customer's industry and specific objectives. GBS enterprise technology stack offerings include: • Analytics and Engineering. GBS's portfolio of analytics services and extensive partner ecosystem help customers gain rapid insights, automate operations, and accelerate their digital transformation journeys. GBS provides software engineering and solutions that enable businesses to run and manage their mission-critical functions, transform their operations and develop new ways of doing business. • Applications . GBS uses advanced technologies and methods to accelerate the creation, modernization, delivery and maintenance of high-quality, secure applications allowing customers to innovate faster while reducing risk, time to market, and total cost of ownership, across industries. GBS's vertical-specific IP includes solutions for insurance; banking and capital markets; and automotive, among others. GBS offerings also includes business process services, which include digital integration and optimization of front and back office processes, and agile process automation. This helps companies to reduce cost, and minimize business disruption, human error, and operational risk while improving customer experiences. Global Infrastructure Services ("GIS") GIS provides a portfolio of technology offerings that deliver predictable outcomes and measurable results, while reducing business risk and operational costs for customers. GIS enterprise stack elements include: • Cloud and Security. GIS helps customers to rapidly modernize by adapting legacy apps to cloud, migrate the right workloads, and securely manage their multi-cloud environments. GIS's security solutions help predict attacks, proactively respond to threats, ensure compliance and protect data, applications and infrastructure. • IT Outsourcing ("ITO") . GIS's ITO services support infrastructure, applications, and workplace IT operations, including hardware, software, physical/virtual end-user devices, collaboration tools, and IT support services. GIS helps customers securely optimize operations to ensure continuity of their systems and respond to new business and workplace demands, while achieving cost takeout, all with limited resources, expertise and budget. GIS offerings also include workplace and mobility services to fit its customer’s employee, business and IT needs from intelligent collaboration, modern device management, digital support services, Internet of Things ("IoT") and mobility services, providing a consumer-like, digital experience. Segment Measures The following table summarizes operating results regularly provided to the CODM by reportable segment and a reconciliation to the financial statements: (in millions) GBS GIS Total Reportable Segments All Other Totals Three Months Ended December 31, 2020 Revenues $ 1,921 $ 2,367 $ 4,288 $ — $ 4,288 Segment profit $ 273 $ 88 $ 361 $ (61) $ 300 Depreciation and amortization (1) $ 53 $ 281 $ 334 $ 27 $ 361 Three Months Ended December 31, 2019 Revenues $ 2,359 $ 2,662 $ 5,021 $ — $ 5,021 Segment profit $ 353 $ 232 $ 585 $ (57) $ 528 Depreciation and amortization (1) $ 61 $ 244 $ 305 $ 28 $ 333 (in millions) GBS GIS Total Reportable Segments All Other Totals Nine Months Ended December 31, 2020 Revenues $ 6,337 $ 7,007 $ 13,344 $ — $ 13,344 Segment profit $ 805 $ 147 $ 952 $ (179) $ 773 Depreciation and amortization (1) $ 162 $ 839 $ 1,001 $ 77 $ 1,078 Nine Months Ended December 31, 2019 Revenues $ 6,803 $ 7,959 $ 14,762 $ — $ 14,762 Segment profit $ 1,078 $ 815 $ 1,893 $ (184) $ 1,709 Depreciation and amortization (1) $ 128 $ 771 $ 899 $ 82 $ 981 (1) Depreciation and amortization as presented excludes amortization of acquired intangible assets of $114 million and $146 million for the three months ended December 31, 2020 and 2019, respectively, and $414 million and $435 million for the nine months ended December 31, 2020 and 2019, respectively. Reconciliation of Reportable Segment Profit to Consolidated Total The Company's management uses segment profit as the measure for assessing performance of its segments. Segment profit is defined as segment revenue less costs of services, segment selling, general and administrative, depreciation and amortization, and other income (excluding the movement in foreign currency exchange rates on DXC's foreign currency denominated assets and liabilities and the related economic hedges). The Company does not allocate to its segments certain operating expenses managed at the corporate level. These unallocated costs include certain corporate function costs, stock-based compensation expense, pension and OPEB actuarial and settlement gains and losses, restructuring costs, transaction, separation and integration-related costs and amortization of acquired intangible assets. Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Profit Total profit for reportable segments $ 361 $ 585 952 $ 1,893 All other loss (61) (57) (179) (184) Interest income 28 33 76 130 Interest expense (82) (93) (284) (288) Restructuring costs (104) (74) (441) (248) Transaction, separation and integration-related costs (96) (68) (307) (226) Amortization of acquired intangible assets (114) (146) (414) (435) Gain on disposition of businesses 2,046 — 2,046 — Pension and OPEB actuarial and settlement losses — — (2) — Goodwill impairment losses — (53) — (2,940) Gain on arbitration award — — — 632 Income (loss) before income taxes $ 1,978 $ 127 $ 1,447 $ (1,666) Management does not use total assets by segment to evaluate segment performance or allocate resources. As a result, assets are not tracked by segment and therefore, total assets by segment is not disclosed. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Dec. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Commitments The Company signed long-term purchase agreements with certain software, hardware, telecommunication, and other service providers to obtain favorable pricing and terms for services, and products that are necessary for the operations of business activities. Under the terms of these agreements, the Company is contractually committed to purchase specified minimums over periods ranging from one Fiscal year Minimum Purchase Commitment (1) (in millions) Remainder of 2021 $ 1,339 2022 1,093 2023 817 2024 227 Total $ 3,476 (1) A portion of the minimum purchase commitments for fiscal 2021 relates to the amounts committed under the HPE preferred vendor agreements. In the normal course of business, the Company may provide certain clients with financial performance guarantees, and at times performance letters of credit or surety bonds. In general, the Company would only be liable for the amounts of these guarantees in the event that non-performance by the Company permits termination of the related contract by the Company’s client. The Company believes it is in compliance with its performance obligations under all service contracts for which there is a financial performance guarantee, and the ultimate liability, if any, incurred in connection with these guarantees will not have a material adverse effect on its consolidated results of operations or financial position. The Company also uses stand-by letters of credit, in lieu of cash, to support various risk management insurance policies. These letters of credit represent a contingent liability and the Company would only be liable if it defaults on its payment obligations on these policies. The following table summarizes the expiration of the Company’s financial guarantees and stand-by letters of credit outstanding as of December 31, 2020: (in millions) Remainder of Fiscal 2021 Fiscal 2022 Fiscal 2023 and Thereafter Totals Surety bonds $ 14 $ 93 $ 87 $ 194 Letters of credit 37 147 527 711 Stand-by letters of credit 36 41 31 108 Totals $ 87 $ 281 $ 645 $ 1,013 The Company generally indemnifies licensees of its proprietary software products against claims brought by third parties alleging infringement of their intellectual property rights, including rights in patents (with or without geographic limitations), copyrights, trademarks, and trade secrets. DXC’s indemnification of its licensees relates to costs arising from court awards, negotiated settlements, and the related legal and internal costs of those licensees. The Company maintains the right, at its own cost, to modify or replace software in order to eliminate any infringement. The Company has not incurred any significant costs related to licensee software indemnification. Contingencies Strauch Fair Labor Standards Act Collective Action : On July 1, 2014, several plaintiffs filed an action in the U.S. District Court for the District of Connecticut on behalf of themselves and a putative nationwide collective of CSC system administrators, alleging CSC’s failure to properly classify these employees as non-exempt under the federal Fair Labor Standards Act ("FLSA"). Plaintiffs alleged similar state-law Rule 23 class claims pursuant to Connecticut and California statutes. Plaintiffs claimed double overtime damages, liquidated damages, and other amounts and remedies. In 2015 the Court entered an order granting conditional certification under the FLSA of the collective of over 4,000 system administrators. Approximately 1,000 system administrators filed consents with the Court to participate in the FLSA collective. The class/collective action is currently made up of approximately 800 individuals who held the title of associate professional or professional system administrator. In June 2017, the Court granted Rule 23 certification of a Connecticut state-law class and a California state-law class consisting of professional system administrators and associate professional system administrators. Senior professional system administrators were found not to qualify for Rule 23 certification under the state-law claims. CSC sought permission to appeal the Rule 23 decision to the Second Circuit Court of Appeals, which was denied. In December 2017, a jury trial was held and a verdict was returned in favor of plaintiffs. On August 6, 2019, the Court issued an order awarding plaintiffs $18.75 million in damages. In September 2019, Plaintiffs filed a motion seeking $14.1 million in attorneys’ fees and costs. In July 2020, the Court issued an order awarding Plaintiffs $8.1 million in attorneys’ fees and costs. The Company disagrees with the jury verdict, the damages award, and the fee award, and is appealing the judgment of the Court. In October 2020, the Company reached an agreement in principle with the plaintiffs to resolve the matter. The Company is finalizing a settlement agreement, which once executed, will be submitted to the Court for approval. Computer Sciences Corporation v. Eric Pulier, et al.: On May 12, 2015, CSC filed a civil complaint in the Court of Chancery of the State of Delaware against Eric Pulier, the former CEO of Service Mesh Inc. ("SMI"), which CSC had acquired in November 2013. The complaint asserted claims for fraud, breach of contract and breach of fiduciary duty, based on allegations that Mr. Pulier had engaged in fraudulent transactions with two employees of the Commonwealth Bank of Australia Ltd. (“CBA”). The Court dismissed CSC’s claim for breach of the implied covenant of good faith, but allowed substantially all of the remaining claims to proceed. Mr. Pulier asserted counter-claims for breach of contract, fraud, negligent representation, rescission, and violations of the California Blue Sky securities law, all of which the Court dismissed in whole or in part, except for claims for breach of Mr. Pulier’s retention agreement. In July 2017, the Court granted a motion by the United States for a 90-day stay of discovery pending the completion of a criminal investigation by the U.S. Attorney’s Office for the Central District of California. In September 2017, a federal grand jury returned an indictment against Mr. Pulier, charging him with conspiracy, securities and wire fraud, obstruction of justice, and other violations of federal law ( United States v. Eric Pulier , CR 17-599-AB). The Government sought an extension of the stay which the Delaware Chancery Court granted. In December 2018, the Government filed an application to dismiss the indictment against Mr. Pulier, which was granted, and the indictment was dismissed with prejudice. In March 2019, the Delaware Chancery Court lifted the stay and denied CSC’s motion for a temporary restraining order and preliminary injunction with respect to certain of Mr. Pulier’s assets. In August 2019, the Company entered into an agreement with Mr. Pulier, resolving all claims and counterclaims in the Delaware litigation through the division of amounts previously held in escrow for post-closing disputes. The Securities and Exchange Commission (“SEC”) has filed a complaint against Mr. Pulier alleging various claims, including for fraud and falsifying books and records ( Securities and Exchange Commission v. Eric Pulier, Case No. 2:17-cv-07124). The case is scheduled for trial in April 2021. In February 2016, Mr. Pulier filed a complaint in Delaware Chancery Court seeking advancement of his legal fees and costs in the civil and criminal actions, pursuant to the terms of his agreements with SMI. The Court ruled that CSC Agility Platform - as the successor to SMI - is liable for advancing 80% of Mr. Pulier’s fees and costs in the civil and criminal actions. Pursuant to agreements with SMI, Mr. Pulier is obligated to repay all amounts advanced to him if it should ultimately be determined that he is not entitled to indemnification. The Company remains obligated to advance amounts for Mr. Pulier’s legal fees and costs to defend the SEC action against him. Kemper Corporate Services, Inc. v. Computer Sciences Corporation: In October 2015, Kemper Corporate Services, Inc. (“Kemper”) filed a demand for arbitration against CSC with the American Arbitration Association (“AAA”), alleging that CSC breached the terms of a 2009 Master Software License and Services Agreement and related Work Orders (the “Agreement”) by failing to complete a software translation and implementation plan by certain contractual deadlines. Kemper claimed breach of contract, seeking approximately $100 million in damages. CSC answered the demand for arbitration denying Kemper’s claims and asserting a counterclaim for unpaid invoices for services rendered by CSC. A single arbitrator conducted an evidentiary hearing on the merits of the claims and counterclaims in April 2017. In October 2017, the arbitrator issued a partial final award, finding for Kemper on its breach of contract theory, awarding Kemper $84.2 million in compensatory damages plus prejudgment interest, denying Kemper’s claim for rescission as moot, and denying CSC’s counterclaim. Kemper moved to confirm the award in federal district court in Texas. CSC moved to vacate the award, and in August 2018, the Magistrate Judge issued its Report and Recommendation denying CSC's vacatur motion. In September 2018, the District Court summarily accepted the Report and Recommendation without further briefing and entered a Final Judgment in the case. The Company promptly filed a notice of appeal to the Fifth Circuit Court of Appeals. Following the submission of briefs, oral argument was held on September 5, 2019. On January 10, 2020, the Court of Appeals issued a decision denying the Company’s appeal. On January 24, 2020, the Company filed a Petition for Rehearing, seeking review by the entire en banc Court of Appeals. On February 14, 2020, the Court of Appeals denied the Company's Petition. The Company has been pursuing coverage for the full scope of the award, interest, and legal fees and expenses, under the Company's applicable insurance policies. Certain carriers have accepted coverage while others have denied coverage. On February 21, 2020, the Company paid the balance of the judgment, which net of insurance recovery totalled $60 million. The Company has since recovered an additional $12.5 million from its insurance carriers. The Company continues to pursue recovery with its insurance carriers. Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise: On August 18, 2016, this purported class and collective action was filed in the U.S. District Court for the Northern District of California, against HP and HPE alleging violations of the Federal Age Discrimination in Employment Act (“ADEA”), the California Fair Employment and Housing Act, California public policy and the California Business and Professions Code. Former business units of HPE now owned by the Company may be proportionately liable for any recovery by plaintiffs in this matter. Plaintiffs seek to certify a nationwide class action under the ADEA comprised of all U.S. residents employed by defendants who had their employment terminated pursuant to a work force reduction (“WFR”) plan and who were 40 years of age or older at the time of termination. The class seeks to cover those impacted by WFRs on or after December 2014. Plaintiffs also seek to represent a Rule 23 class under California law comprised of all persons 40 years of age or older employed by defendants in the state of California and terminated pursuant to a WFR plan on or after August 18, 2012. In January 2017, defendants filed a partial motion to dismiss and a motion to compel arbitration of claims by certain named and opt-in plaintiffs who had signed release agreements as part of their WFR packages. In September 2017, the Court denied the partial motion to dismiss without prejudice, but granted defendants’ motions to compel arbitration for those named and opt-in plaintiffs. The Court stayed the entire action pending arbitration for these individuals and administratively closed the case. A mediation was held in October 2018 with the 16 named and opt-in plaintiffs who were involved in the case at that time. A settlement was reached, which included seven plaintiffs who were employed by former business units of HPE that are now owned by the Company. In June 2019, a second mediation was held with 145 additional opt-in plaintiffs who were compelled to arbitration pursuant to their release agreements. In December 2019, a settlement was reached with 142 of the opt-in plaintiffs, 35 of whom were employed by former business units of HPE that are now owned by the Company, and for which the Company was liable. In December 2020, Plaintiffs filed a motion for preliminary certification of the collective action, which Defendants intend to oppose. A hearing on the motion has been scheduled for April 15, 2021. Former business units of the Company now owned by Perspecta may be proportionately liable for any recovery by plaintiffs in this matter. Oracle America, Inc., et al. v. Hewlett Packard Enterprise Company: On March 22, 2016, Oracle filed a complaint against HPE in the Northern District of California, alleging copyright infringement, interference with contract, intentional interference with prospective economic relations, and unfair competition. The litigation relates in part to former business units of HPE that are now owned by the Company. The Company may be required to indemnify HPE for a portion of any recovery by Oracle in the litigation related to these business units. Oracle’s claims arise primarily out of HPE’s prior relationship with a third-party maintenance provider named Terix Computer Company, Inc. (“Terix”). Oracle claims that Terix infringed its copyrights while acting as HPE’s subcontractor for certain customers of HPE’s multivendor support business. Oracle claims that HPE is liable for vicarious and contributory infringement arising from the alleged actions of Terix and for direct infringement arising from its own alleged conduct. On January 29, 2019, the court granted HPE’s motion for summary judgment and denied Oracle’s motion for summary judgment, resolving the matter in HPE’s favor. Oracle appealed the judgment to the U.S. Court of Appeals for the Ninth Circuit. In August 2020, the court granted Oracle’s appeal in part. The case has been remanded to the District Court for further proceedings. In re DXC Technology Company Securities Litigation: On December 27, 2018, a purported class action lawsuit was filed in the United States District Court for the Eastern District of Virginia against the Company and two of its current officers. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and is premised on allegedly false and/or misleading statements, and alleged non-disclosure of material facts, regarding the Company’s business, operations, prospects and performance during the proposed class period of February 8, 2018 to November 6, 2018. The Company moved to dismiss the claims in their entirety, and on June 2, 2020, the court granted the Company’s motion, dismissing all claims and entering judgment in the Company’s favor. On July 1, 2020, the plaintiffs filed a notice of appeal to the U.S. Court of Appeals for the Fourth Circuit. The appeal remains pending. In March 2019, three related shareholder derivative lawsuits were filed in the Eighth Judicial District Court of the State of Nevada, in and for Clark County, against one of the Company’s current officers and a former officer as well as members of the Company’s board of directors, asserting claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment. By agreement of the parties and order of the court, those lawsuits were consolidated on July 18, 2019, and are presently stayed pending the outcome of the appeal of the Eastern District of Virginia matter. On August 20, 2019, a purported class action lawsuit was filed in the Superior Court of the State of California, County of Santa Clara, against the Company, directors of the Company, and a former officer of the Company, among other defendants. On September 16, 2019, a substantially similar purported class action lawsuit was filed in the United States District Court for the Northern District of California against the Company, directors of the Company, and a former officer of the Company, among other defendants. On November 8, 2019, a third purported class action lawsuit was filed in the Superior Court of the State of California, County of San Mateo, against the Company, directors of the Company, and a former officer of the Company, among other defendants. The third lawsuit was voluntarily dismissed by the plaintiff and re-filed in the Superior Court of the State of California, County of Santa Clara on November 26, 2019, and thereafter was consolidated with the earlier-filed action in the same court on December 10, 2019. The California lawsuits assert claims under Sections 11, 12 and 15 of the Securities Act of 1933, as amended, and are premised on allegedly false and/or misleading statements, and alleged non-disclosure of material facts, regarding the Company’s prospects and expected performance. Plaintiff in the federal action filed an amended complaint on January 8, 2020. The putative class of plaintiffs in these cases includes all persons who acquired shares of the Company’s common stock pursuant to the offering documents filed with the Securities and Exchange Commission in connection with the April 2017 transaction that formed DXC. On July 15, 2020, the Superior Court of California, County of Santa Clara, denied the Company’s motion to stay the state court case but extended the Company’s deadline to seek dismissal of the state action, until after a decision on the Company’s motion to dismiss the federal action. The Company has since moved to dismiss the state action, and the court has continued the motion until after the outcome of the federal action. On July 27, 2020, the United States District Court for the Northern District of California granted the Company’s motion to dismiss the federal action. The Court’s order permitted plaintiffs to amend and refile their complaint within 60 days, and on September 25, 2020, the plaintiffs filed an amended complaint. On November 12, 2020, the Company filed a motion to dismiss the amended complaint. A hearing on the motion is scheduled for April 29, 2021. On October 2, 2019, a shareholder derivative lawsuit was filed in the Eighth Judicial District Court of the State of Nevada, in and for Clark County, asserting various claims, including for breach of fiduciary duty and unjust enrichment, and challenging certain sales of securities by officers under Rule 10b5-1 plans. The shareholder filed this action after making a demand on the board of directors, alleging breaches of fiduciary duty, corporate waste and disclosure violations, and demanding that the Board take certain actions to evaluate the allegations and respond. The Company’s board of directors analyzed the demand, and has determined to defer its decision on the demand pending developments in the securities and derivative lawsuits described above. The Company moved to dismiss the complaint on the basis that the Board’s decision to defer action was not a refusal of the demand and was within its discretion. The Company’s motion to dismiss was denied on January 22, 2020. By agreement of the parties and order of the court, the case is presently stayed, pending the outcome of the appeal of the Eastern District of Virginia matter. On March 31, 2020, a group of individual shareholders filed a complaint in the United States District Court for the Northern District of California, asserting non-class claims based on allegations substantially similar to those at issue in the earlier-filed putative class action complaints pending in the Northern District of California and Eastern District of Virginia. The plaintiffs assert claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and under Sections 11 and 15 of the Securities Act of 1933, as amended. On April 29, 2020, the court granted an administrative motion to relate the case with the earlier-filed putative class action pending in the Northern District of California. And on May 13, 2020, the parties filed a stipulation requesting to stay the case subject to resolution of the motions to dismiss in the Northern District of California and Eastern District of Virginia class actions. The Company believes that the lawsuits described above are without merit, and it intends to vigorously defend them. Voluntary Disclosure of Certain Possible Sanctions Law Violations: On February 2, 2017, CSC submitted an initial notification of voluntary disclosure to the U.S. Department of Treasury, Office of Foreign Assets Control ("OFAC") regarding certain possible violations of U.S. sanctions laws pertaining to insurance premium data and claims data processed by two partially-owned joint ventures of Xchanging, which CSC acquired during the first quarter of fiscal 2017. A copy of the disclosure was also provided to Her Majesty’s Treasury Office of Financial Sanctions Implementation in the United Kingdom. The Company has substantially completed its internal investigation. The Company provided supplemental information to OFAC on January 31, 2020 and continues to work with OFAC on these issues. Perspecta Arbitration: In October 2019, Perspecta Inc. (“Perspecta”) submitted a demand for arbitration claiming that in June 2018 DXC breached certain obligations under the Separation and Distribution Agreement ("SDA") between Perspecta and DXC and seeking at least $120 million in alleged damages. During the course of discovery, Perspecta increased the amount of its alleged damages, first to $500 million and then to over $800 million. Perspecta has since increased its damages calculations to include interest, bringing its total claim to $990 million. The Company believes there is no valid basis for Perspecta's claims for these amounts. In its arbitration demand, Perspecta also challenges $39 million in invoices issued by DXC in June 2019 under its IT Services Agreement with Perspecta ("ITSA"). Perspecta subsequently challenged an additional $31 million sought by DXC in August 2020 under the ITSA. DXC believes the invoices were properly issued and the amounts are owed by Perspecta. In October 2020, a hearing was held before an arbitration panel, during which the Company and Perspecta each presented evidence on the claims at issue. In December 2020, the parties presented closing arguments and the case was submitted. The parties are awaiting a decision from the arbitration panel. In addition to the matters noted above, the Company is currently subject in the normal course of business to various claims and contingencies arising from, among other things, disputes with customers, vendors, employees, contract counterparties and other parties, as well as securities matters, environmental matters, matters concerning the licensing and use of intellectual property, and inquiries and investigations by regulatory authorities and government agencies. Some of these disputes involve or may involve litigation. The financial statements reflect the treatment of claims and contingencies based on management's view of the expected outcome. DXC consults with outside legal counsel on issues related to litigation and regulatory compliance and seeks input from other experts and advisors with respect to matters in the ordinary course of business. Although the outcome of these and other matters cannot be predicted with certainty, and the impact of the final resolution of these and other matters on the Company’s results of operations in a particular subsequent reporting period could be material and adverse, management does not believe based on information currently available to the Company, that the resolution of any of the matters currently pending against the Company will have a material adverse effect on the financial position of the Company or the ability of the Company to meet its financial obligations as they become due. Unless otherwise noted, the Company is unable to determine at this time a reasonable estimate of a possible loss or range of losses associated with the foregoing disclosed contingent matters. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation In order to make this report easier to read, DXC refers throughout to (i) the interim unaudited Condensed Consolidated Financial Statements as the “financial statements,” (ii) the Condensed Consolidated Statements of Operations as the “statements of operations,” (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss) as the "statements of comprehensive income," (iv) the Condensed Consolidated Balance Sheets as the “balance sheets,” and (v) the Condensed Consolidated Statements of Cash Flows as the “statements of cash flows.” In addition, references throughout to numbered “Notes” refer to the numbered Notes in these Notes to Condensed Consolidated Financial Statements, unless otherwise noted. The accompanying financial statements include the accounts of DXC, its consolidated subsidiaries, and those business entities in which DXC maintains a controlling interest. Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. Other investments are accounted for by the cost method. Non-controlling interests are presented as a separate component within equity in the balance sheets. Net earnings attributable to the non-controlling interests are presented separately in the statements of operations and comprehensive income attributable to non-controlling interests are presented separately in the statements of comprehensive income. All intercompany transactions and balances have been eliminated. Certain amounts reported in the previous year have been reclassified to conform to the current year presentation. |
Use of Estimates | Use of EstimatesThe preparation of financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions that affect amounts reported in the financial statements. The Company bases its estimates on assumptions regarding historical experience, currently available information and anticipated developments that it believes are reasonable and appropriate. However, because the use of estimates involves an inherent degree of uncertainty, actual results could differ from those estimates. The severity, magnitude and duration, as well as the economic consequences of the coronavirus disease 2019 ("COVID-19") pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of the Company's management, the accompanying financial statements of DXC contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company's financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full fiscal year. |
Allowance for Credit Losses | Allowance for Credit Losses Effective April 1, 2020, the Company adopted Accounting Standards Update ("ASU") 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” using the modified retrospective method. Refer to Note 2 - "Recent Accounting Pronouncements" and Note 6 - "Receivables" for further discussion of the impact of adoption and other required disclosures. The amendments in this update changed the guidance for credit losses to an expected loss model rather than an incurred loss model. Financial assets subject to impairment under an expected credit loss model include billed and unbilled receivables, other receivables, and contract assets. Certain off-balance sheet arrangements, such as financial guarantees associated with receivables securitization facilities, are also subject to the guidance of ASU 2016-13. Under an expected credit loss model, the Company immediately recognizes an estimate of credit losses expected to occur over the remaining life of financial assets that are in the scope of ASU 2016-13. DXC considers all available relevant information when estimating expected credit losses, including past events, current market conditions and forecasts and their implications for expected credit losses. |
Recent Accounting Pronouncements | During the nine months ended December 31, 2020, DXC adopted the following Accounting Standards Updates ("ASU") issued by the Financial Accounting Standards Board: Date Issued and ASU Date Adopted and Method Description Impact June 2016 ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” April 1, 2020 Modified Retrospective This update requires the measurement and recognition of expected credit losses using the current expected credit loss model for financial assets held at amortized cost, which includes the Company’s trade accounts receivable, certain financial instruments and contract assets. It replaces the existing incurred loss impairment model with an expected loss methodology. The recorded credit losses are adjusted each period for changes in expected lifetime credit losses. The standard requires a cumulative effect adjustment to the statement of financial position as of the beginning of the first reporting period in which the guidance is effective. The Company adopted this standard using the modified retrospective approach and recorded an immaterial cumulative effect adjustment in retained earnings as of April 1, 2020. August 2018 ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract" April 1, 2020 Prospective This update helps entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license. Entities have the option to apply this standard prospectively to all implementation costs incurred after the date of adoption or retrospectively. The Company adopted this standard using the prospective method and determined that the adoption of ASU 2018-15 had no material impact to its condensed consolidated financial statements. The following ASUs were recently issued but have not yet been adopted by DXC: Date Issued and ASU DXC Effective Date Description Impact December 2019 ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" Fiscal 2022 This update is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. Early adoption of this update is permitted. The Company is currently evaluating the potential impact this standard may have on its financial statements in future reporting periods. Other recently issued ASUs effective after December 31, 2020 are not expected to have a material effect on DXC's consolidated financial statements. |
Recent Accounting Pronounceme_2
Recent Accounting Pronouncements (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Accounting Policies [Abstract] | |
Schedule of Recently Adopted Accounting Pronouncements and New Accounting Pronouncements | During the nine months ended December 31, 2020, DXC adopted the following Accounting Standards Updates ("ASU") issued by the Financial Accounting Standards Board: Date Issued and ASU Date Adopted and Method Description Impact June 2016 ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” April 1, 2020 Modified Retrospective This update requires the measurement and recognition of expected credit losses using the current expected credit loss model for financial assets held at amortized cost, which includes the Company’s trade accounts receivable, certain financial instruments and contract assets. It replaces the existing incurred loss impairment model with an expected loss methodology. The recorded credit losses are adjusted each period for changes in expected lifetime credit losses. The standard requires a cumulative effect adjustment to the statement of financial position as of the beginning of the first reporting period in which the guidance is effective. The Company adopted this standard using the modified retrospective approach and recorded an immaterial cumulative effect adjustment in retained earnings as of April 1, 2020. August 2018 ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract" April 1, 2020 Prospective This update helps entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license. Entities have the option to apply this standard prospectively to all implementation costs incurred after the date of adoption or retrospectively. The Company adopted this standard using the prospective method and determined that the adoption of ASU 2018-15 had no material impact to its condensed consolidated financial statements. The following ASUs were recently issued but have not yet been adopted by DXC: Date Issued and ASU DXC Effective Date Description Impact December 2019 ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" Fiscal 2022 This update is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. Early adoption of this update is permitted. The Company is currently evaluating the potential impact this standard may have on its financial statements in future reporting periods. |
Acquisitions (Tables)
Acquisitions (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Business Combinations [Abstract] | |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | The Company's allocation of the purchase price to the assets acquired and liabilities assumed as of the Luxoft acquisition date is as follows: (in millions) Fair Value Cash and cash equivalents $ 113 Accounts receivable 233 Other current assets 15 Total current assets 361 Property and equipment 31 Intangible assets 577 Other assets 99 Total assets acquired 1,068 Accounts payable, accrued payroll, accrued expenses, and other current liabilities (121) Deferred revenue (8) Long-term deferred tax liabilities and income tax payable (106) Other liabilities (72) Total liabilities assumed (307) Net identifiable assets acquired 761 Goodwill 1,262 Total consideration transferred $ 2,023 |
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination | Below are the estimated useful lives of the acquired intangibles: Estimated Useful Lives (Years) Customer related intangibles 10 Trade names 20 Developed technology 3 Third-party purchased software 3 |
Divestitures (Tables)
Divestitures (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Schedule of Assets and Liabilities Distributed | The following is a summary of the assets and liabilities distributed as part of the HHS Sale on October 1, 2020: (in millions) Assets: Cash and cash equivalents $ 8 Accounts receivable, net 295 Prepaid expenses 39 Other current assets 2 Total current assets 344 Intangible assets, net 1,308 Operating right-of-use assets, net 74 Goodwill 1,354 Property and equipment, net 46 Other assets 54 Total non-current assets 2,836 Total assets $ 3,180 Liabilities: Accounts payable $ 79 Accrued payroll and related costs 13 Current operating lease liabilities 27 Accrued expenses and other current liabilities 36 Deferred revenue and advance contract payments 20 Total current liabilities 175 Non-current deferred revenue 32 Long-term operating lease liabilities 48 Other long term liabilities 2 Total long-term liabilities 82 Total liabilities $ 257 |
Earnings (Loss) per Share (Tabl
Earnings (Loss) per Share (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings (Loss) per Share | The following table reflects the calculation of basic and diluted EPS: Three Months Ended Nine Months Ended (in millions, except per-share amounts) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Net income (loss) attributable to DXC common shareholders: $ 1,098 $ 82 $ 649 $ (1,874) Common share information: Weighted average common shares outstanding for basic EPS 254.32 255.09 254.03 260.24 Dilutive effect of stock options and equity awards 1.43 0.96 1.17 — Weighted average common shares outstanding for diluted EPS 255.75 256.05 255.20 260.24 Earnings (loss) per share: Basic $ 4.32 $ 0.32 $ 2.55 $ (7.20) Diluted $ 4.29 $ 0.32 $ 2.54 $ (7.20) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The number of awards excluded were as follows: Three Months Ended Nine Months Ended December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Stock Options 1,519,611 621,028 1,582,568 818,490 Restricted Stock Units 1,418,752 2,125,734 1,628,968 2,116,898 Performance-based Restricted Stock Units 836,866 — 723,754 351,410 |
Receivables (Tables)
Receivables (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Receivables [Abstract] | |
Summary of Transfer of Assets Accounted for as Sales, Deferred Purchase Price | The following table is a reconciliation of the beginning and ending balance of the DPP for the Receivables Facility: (in millions) As of and for the Nine Months Ended December 31, 2019 Beginning balance $ 574 Transfers of receivables 1,214 Collections (1,265) Change in funding availability 2 Facility amendments (525) Ending balance $ — The following table is a reconciliation of the beginning and ending balances of the DPP for the DE Receivables Facility: (in millions) As of and for the Nine Months Ended December 31, 2020 Beginning balance $ 103 Transfers of receivables 417 Collections (420) Change in funding availability 2 Facility amendments (102) Ending balance $ — |
Summary of Allowance for Doubtful Accounts for Trade Accounts Receivable | The following table presents the activity in the allowance for doubtful accounts for trade accounts receivable: (in millions) As of and for the Nine Months Ended December 31, 2020 Beginning balance $ 74 Impact of adoption of the Credit Loss Standard 4 Provisions for losses on accounts receivable 52 Other adjustments to allowance and write-off's 69 Ending balance $ 199 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Leases [Abstract] | |
Components of Lease Expense and Supplemental Cash Flow Information Related to Leases | The components of lease expense were as follows: Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Operating lease cost $ 156 $ 166 $ 463 $ 506 Short-term lease cost 14 17 40 41 Variable lease cost 17 9 40 35 Sublease income (10) (9) (32) (28) Total operating costs $ 177 $ 183 $ 511 $ 554 Finance lease cost: Amortization of right-of-use assets $ 107 $ 90 $ 322 $ 339 Interest on lease liabilities 10 16 35 50 Total finance lease cost $ 117 $ 106 $ 357 $ 389 |
Supplemental Balance Sheet Information Related to Leases | Cash payments made from variable lease costs and short-term leases are not included in the measurement of operating and finance lease liabilities, and as such, are excluded from the supplemental cash flow information stated below. In addition, for the supplemental non-cash information on operating and finance leases, please refer to Note 19 - "Cash Flows." Supplemental cash flow information related to leases was as follows: Nine Months Ended (in millions) December 31, 2020 December 31, 2019 Cash paid for amounts included in the measurement of: Operating cash flows used in operating leases $ 463 $ 506 Operating cash flows used in finance leases $ 35 $ 50 Financing cash flows used in finance leases $ 430 $ 436 Supplemental balance sheet information related to leases was as follows: As of (in millions) Balance Sheet Line Item December 31, 2020 March 31, 2020 Assets: ROU operating lease assets Operating right-of-use assets, net $ 1,459 $ 1,428 ROU finance lease assets Property and Equipment, net 971 1,220 Total $ 2,430 $ 2,648 Liabilities: Current Operating lease Current operating lease liabilities $ 450 $ 482 Finance lease Short-term debt and current maturities of long-term debt 431 444 Total $ 881 $ 926 Non-current Operating lease Non-current operating lease liabilities $ 1,113 $ 1,063 Finance lease Long-term debt, net of current maturities 545 602 Total $ 1,658 $ 1,665 The following table provides information on the weighted average remaining lease term and weighted average discount rate for operating and finance leases: As of December 31, 2020 March 31, 2020 Weighted Average remaining lease term: Years Operating leases 4.8 4.8 Finance leases 2.7 2.7 Weighted average remaining discount rate: Rate Operating leases 4.0 % 4.0 % Finance leases 3.8 % 6.4 % |
Maturities of Lease Liabilities | The following maturity analysis presents expected undiscounted cash payments for operating and finance leases on an annual basis as of December 31, 2020: Fiscal year Operating Leases (in millions) Real Estate Equipment Finance Leases Remainder of 2021 $ 117 $ 15 $ 128 2022 412 42 419 2023 337 24 275 2024 262 11 139 2025 192 5 48 Thereafter 297 3 6 Total lease payments 1,617 100 1,015 Less: imputed interest (151) (3) (39) Total payments $ 1,466 $ 97 $ 976 |
Maturities of Lease Liabilities | The following maturity analysis presents expected undiscounted cash payments for operating and finance leases on an annual basis as of December 31, 2020: Fiscal year Operating Leases (in millions) Real Estate Equipment Finance Leases Remainder of 2021 $ 117 $ 15 $ 128 2022 412 42 419 2023 337 24 275 2024 262 11 139 2025 192 5 48 Thereafter 297 3 6 Total lease payments 1,617 100 1,015 Less: imputed interest (151) (3) (39) Total payments $ 1,466 $ 97 $ 976 |
Fair Value (Tables)
Fair Value (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis | The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis excluding pension assets and derivative assets and liabilities. See Note 9 - "Derivative and Hedging Activities" for information about the fair value of the Company's derivative assets and liabilities. There were no transfers among any of the levels during the periods presented. Fair Value Hierarchy (in millions) December 31, 2020 Assets: Fair Value Level 1 Level 2 Level 3 Money market funds and money market deposit accounts $ 262 $ 262 $ — $ — U.S. treasury bills (1) 250 250 — — Time deposits (1) 349 349 — — Other debt securities (2) 62 — 59 3 Total assets $ 923 $ 861 $ 59 $ 3 Liabilities: Contingent consideration $ 40 $ — $ — $ 40 Total liabilities $ 40 $ — $ — $ 40 March 31, 2020 Assets: Fair Value Level 1 Level 2 Level 3 Money market funds and money market deposit accounts $ 156 $ 156 $ — $ — Time deposits (1) 595 595 — — Other debt securities (2) 51 — 48 3 Deferred purchase price receivable 103 — — 103 Total assets $ 905 $ 751 $ 48 $ 106 Liabilities: Contingent consideration $ 46 $ — $ — $ 46 Total liabilities $ 46 $ — $ — $ 46 (1) Cost basis approximated fair value due to the short period of time to maturity. (2) Other debt securities include available-for-sale investments with Level 2 inputs with cost bases of $59 million and $37 million, and unrealized gains of $0 million and $11 million, as of December 31, 2020 and March 31, 2020, respectively. During the quarter, previously held investments were sold and the proceeds were used to purchase new investments. The gain of $17 million from the sale was included in other income, net. |
Derivative and Hedging Activi_2
Derivative and Hedging Activities (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivatives Not Designated For Hedge Accounting | The following table presents the pretax amounts impacting income related to designated and non-designated foreign currency forward contracts: For the Three Months Ended For the Nine Months Ended (in millions) Statement of Operations Line Item December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Foreign currency forward contracts Other expense (income), net $ 16 $ 1 $ 74 $ (21) |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The following tables present the fair values of derivative instruments included in the balance sheets: Derivative Assets As of (in millions) Balance Sheet Line Item December 31, 2020 March 31, 2020 Derivatives designated for hedge accounting: Foreign currency forward contracts Other current assets $ 9 $ — Total fair value of derivatives designated for hedge accounting $ 9 $ — Derivatives not designated for hedge accounting: Foreign currency forward contracts Other current assets $ 6 $ 16 Total fair value of derivatives not designated for hedge accounting $ 6 $ 16 Derivative Liabilities As of (in millions) Balance Sheet Line Item December 31, 2020 March 31, 2020 Derivatives designated for hedge accounting: Foreign currency forward contracts Accrued expenses and other current liabilities $ 5 $ 20 Total fair value of derivatives designated for hedge accounting: $ 5 $ 20 Derivatives not designated for hedge accounting: Foreign currency forward contracts Accrued expenses and other current liabilities $ 17 $ 12 Total fair value of derivatives not designated for hedge accounting $ 17 $ 12 |
Intangible Assets (Tables)
Intangible Assets (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Summary of Amortizable Intangible Assets | Intangible assets consisted of the following: As of December 31, 2020 (in millions) Gross Carrying Value Accumulated Amortization Net Carrying Value Software $ 4,001 $ 2,891 $ 1,110 Customer related intangible assets 4,296 1,606 2,690 Other intangible assets 267 48 219 Total intangible assets $ 8,564 $ 4,545 $ 4,019 As of March 31, 2020 (in millions) Gross Carrying Value Accumulated Amortization Net Carrying Value Software $ 4,048 $ 2,614 $ 1,434 Customer related intangible assets 5,795 1,697 4,098 Other intangible assets 235 36 199 Total intangible assets $ 10,078 $ 4,347 $ 5,731 |
Schedule of Components of Amortization Expense | The components of amortization expense were as follows: Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Intangible asset amortization $ 224 $ 272 $ 735 $ 747 Transition and transformation contract cost amortization (1) 66 71 194 197 Total amortization expense $ 290 $ 343 $ 929 $ 944 (1) Transition and transformation contract costs are included within other assets on the balance sheet. |
Estimated Future Amortization of Intangible Assets | Estimated future amortization related to intangible assets as of December 31, 2020 is as follows: Fiscal Year (in millions) Remainder of 2021 $ 236 2022 $ 821 2023 $ 740 2024 $ 650 2025 $ 535 |
Goodwill (Tables)
Goodwill (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Summary of Changes in the Carrying Amount of Goodwill by Segment | The following table summarizes the changes in the carrying amount of goodwill, by segment, as of December 31, 2020. (in millions) GBS GIS Total Goodwill, gross $ 6,507 $ 5,066 $ 11,573 Accumulated impairment losses (4,490) (5,066) (9,556) Balance as of March 31, 2020, net $ 2,017 $ — $ 2,017 Acquisition related adjustments 18 — 18 Divestitures (1,355) — (1,355) Assets held for sale (4) — (4) Foreign currency translation 60 — 60 Goodwill, gross 5,226 5,066 10,292 Accumulated impairment losses (4,490) (5,066) (9,556) Balance as of December 31, 2020, net $ 736 $ — $ 736 |
Debt (Tables)
Debt (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Debt Disclosure [Abstract] | |
Schedule of Debt | The following is a summary of the Company's debt: (in millions) Interest Rates Fiscal Year Maturities December 31, 2020 March 31, 2020 Short-term debt and current maturities of long-term debt Commercial paper (1) (0.22)% - 0.44% 2021 - 2022 $ 112 $ 542 Current maturities of long-term debt Various 2021 - 2022 252 290 Current maturities of finance lease liabilities 0.62% - 18.47% 2021 - 2022 431 444 Short-term debt and current maturities of long-term debt $ 795 $ 1,276 Long-term debt, net of current maturities AUD term loan 0.94% - 0.96% 2022 — 489 GBP term loan 0.88% - 1.46% 2022 — 556 EUR term loan 0.65% 2022 - 2023 — 822 EUR term loan 0.80% (2) 2023 - 2024 488 821 USD term loan 1.40% - 2.24% 2025 — 480 $274 million Senior notes 4.45% 2023 276 276 $171 million Senior notes 4.45% 2023 172 172 $500 million Senior notes 4.25% 2025 504 505 $500 million Senior notes 4.00% 2024 497 — $500 million Senior notes 4.13% 2026 496 — £250 million Senior notes 2.75% 2025 339 307 €650 million Senior notes 1.75% 2026 792 709 $500 million Senior notes 4.75% 2028 507 507 $234 million Senior notes 7.45% 2030 269 271 Revolving credit facility 1.26% - 2.08% 2024 - 2025 — 1,500 Lease credit facility 1.15% - 1.99% 2021 - 2023 — 11 Finance lease liabilities 0.62% - 18.47% 2021 - 2027 976 1,046 Borrowings for assets acquired under long-term financing 0.00% - 6.39% 2021 - 2027 742 802 Mandatorily redeemable preferred stock outstanding 6.00% 2023 63 62 Other borrowings Various 2021 - 2022 6 70 Long-term debt 6,127 9,406 Less: current maturities 683 734 Long-term debt, net of current maturities $ 5,444 $ 8,672 (1) At DXC's option, DXC can borrow up to a maximum of €1 billion or its equivalent in €, £, and $. (2) At DXC's option, the EUR term loan bears interest at the Eurocurrency Rate for a one-, two-, three-, or six-month interest period, plus a margin between 0.55% and 1.05%, based on published credit ratings of DXC. |
Revenue (Tables)
Revenue (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Summary of Revenue Disaggregated by Geography | The following table presents DXC's revenues disaggregated by geography, based on the location of incorporation of the DXC entity providing the related goods or services: Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 United States $ 1,290 $ 1,843 $ 4,665 $ 5,500 United Kingdom 607 707 1,759 2,100 Other Europe 1,335 1,329 3,784 3,819 Australia 377 380 1,128 1,119 Other International 679 762 2,008 2,224 Total Revenues $ 4,288 $ 5,021 $ 13,344 $ 14,762 |
Summary of Contract Assets and Liabilities | The following table provides information about the balances of the Company's trade receivables and contract assets and contract liabilities: As of (in millions) December 31, 2020 March 31, 2020 Trade receivables, net $ 2,785 $ 3,059 Contract assets $ 418 $ 454 Contract liabilities $ 1,768 $ 1,756 Change in contract liabilities were as follows: Nine Months Ended (in millions) December 31, 2020 (1) December 31, 2019 Balance, beginning of period $ 1,756 $ 1,886 Deferred revenue 2,111 2,091 Recognition of deferred revenue (2,137) (2,137) Currency translation adjustment 146 12 Other (108) (36) Balance, end of period $ 1,768 $ 1,816 |
Restructuring Costs (Tables)
Restructuring Costs (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Restructuring Costs [Abstract] | |
Schedule of Restructuring Expense | The composition of restructuring liabilities by financial statement line item is as follows: As of (in millions) December 31, 2020 Accrued expenses and other current liabilities $ 261 Other long-term liabilities 60 Total $ 321 |
Schedule of Restructuring Liability | Restructuring Liability Reconciliations by Plan Restructuring Liability as of March 31, 2020 Costs Expensed, Net of Reversals (1) Costs Not Affecting Restructuring Liability (2) Cash Paid Other (3) Restructuring Liability as of December 31, 2020 Fiscal 2021 Plan Workforce Reductions $ — $ 416 $ (9) $ (210) $ 9 $ 206 Facilities Costs — 25 (9) (11) (1) 4 Total $ — $ 441 $ (18) $ (221) $ 8 $ 210 Fiscal 2020 Plan Workforce Reductions (4) $ 74 $ 7 $ 2 $ (49) $ 5 $ 39 Facilities Costs 2 (4) 4 (2) — — Total $ 76 $ 3 $ 6 $ (51) $ 5 $ 39 Fiscal 2019 Plan Workforce Reductions $ 25 $ (2) $ (3) $ (13) $ 2 $ 9 Facilities Costs 5 (3) 2 — 1 5 Total $ 30 $ (5) $ (1) $ (13) $ 3 $ 14 Other Prior Year Plans Workforce Reductions $ 24 $ 1 $ 2 $ (14) $ 2 $ 15 Facilities Costs — — — — — — Total $ 24 $ 1 $ 2 $ (14) $ 2 $ 15 Acquired Liabilities Workforce Reductions $ 39 $ 1 $ — $ (7) $ 1 $ 34 Facilities Costs 11 — 1 (3) — 9 Total $ 50 $ 1 $ 1 $ (10) $ 1 $ 43 (1) Costs expensed, net of reversals include $11 million, $10 million, and $3 million of costs reversed from the Fiscal 2020 Plan, Fiscal 2019 Plan and Other Prior Year Plans, respectively. (2) Costs Not Affecting Restructuring Liability include pension benefit augmentations recorded as a pension liability, asset impairments and restructuring costs associated with right-of-use assets. (3) Other include foreign currency translation adjustments. (4) Fiscal 2020 workforce reductions includes a $14 million adjustment to restructuring expense related to the prior year. |
Pension and Other Benefit Pla_2
Pension and Other Benefit Plans (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Retirement Benefits [Abstract] | |
Schedule of Defined Benefit Plans Disclosures | The components of net periodic pension income were: Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Service cost $ 23 $ 23 $ 68 $ 69 Interest cost 62 60 181 177 Expected return on assets (163) (161) (477) (476) Amortization of prior service costs (2) (2) (6) (6) Contractual termination benefit — — 3 17 Curtailment gain — — (9) — Recognition of actuarial loss — — 11 — Net periodic pension income $ (80) $ (80) $ (229) $ (219) |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Equity [Abstract] | |
Class of Treasury Stock | The details of shares repurchased during the nine months ended December 31, 2019 are shown below: Fiscal 2020 Fiscal Period Number of Shares Repurchased Average Price Per Share Amount (in millions) 1st Quarter Open market purchases 5,510,415 $ 54.44 $ 300 Accelerated stock repurchases 1,849,194 $ 54.08 100 1st Quarter Total 7,359,609 $ 54.35 400 2nd Quarter Open market purchases 4,414,840 $ 33.96 150 Accelerated stock repurchases 1,805,350 $ 55.39 100 2nd Quarter Total 6,220,190 $ 40.18 250 3rd Quarter Open market purchases 2,353,852 $ 36.68 86 Accelerated stock repurchases — $ — — 3rd Quarter Total 2,353,852 $ 36.68 86 Total 15,933,651 $ 46.21 $ 736 |
Schedule of Accumulated Other Comprehensive Income (Loss) | The following table shows the changes in accumulated other comprehensive income (loss), net of taxes: (in millions) Foreign Currency Translation Adjustments Cash Flow Hedges Available-for-sale Securities Pension and Other Post-retirement Benefit Plans Accumulated Other Comprehensive Loss Balance at March 31, 2020 $ (851) $ (20) $ 9 $ 259 $ (603) Current-period other comprehensive income 197 12 (6) — 203 Amounts reclassified from accumulated other comprehensive loss — 6 — (13) (7) Balance at December 31, 2020 $ (654) $ (2) $ 3 $ 246 $ (407) (in millions) Foreign Currency Translation Adjustments Cash Flow Hedges Available-for-sale Securities Pension and Other Post-retirement Benefit Plans Accumulated Other Comprehensive Loss Balance at March 31, 2019 $ (517) $ (3) $ 9 $ 267 $ (244) Current-period other comprehensive loss 78 (4) 2 — 76 Amounts reclassified from accumulated other comprehensive income (loss) — (2) — (6) (8) Balance at December 31, 2019 $ (439) $ (9) $ 11 $ 261 $ (176) |
Stock Incentive Plans (Tables)
Stock Incentive Plans (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Share Based Compensation Shares Authorized Under Stock Option Plans | The Board has reserved for issuance shares of DXC common stock, par value $0.01 per share, under each of the plans as detailed below: As of December 31, 2020 Reserved for Issuance Available for Future Grants DXC Employee Equity Plan 51,200,000 32,794,274 DXC Director Equity Plan 745,000 435,951 DXC Share Purchase Plan 250,000 165,185 Total 52,195,000 33,395,410 |
Disclosure of Share Based Compensation Arrangements by Share Based Payment Award | Stock Options Number of Option Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (in millions) Outstanding as of March 31, 2020 1,869,815 $ 29.92 4.27 $ — Granted — $ — Exercised (39,601) $ 17.43 $ — Canceled/Forfeited — $ — Expired (82,614) $ 31.24 Outstanding as of December 31, 2020 1,747,600 $ 30.11 3.73 $ 3 Vested and exercisable as of December 31, 2020 1,747,600 $ 30.11 3.73 $ 3 Restricted Stocks Employee Equity Plan Director Equity Plan Number of Weighted Number of Weighted Average Grant Date Fair Value Outstanding as of March 31, 2020 4,174,476 $ 55.45 114,615 $ 37.69 Granted 7,576,602 $ 18.67 118,500 $ 18.82 Settled (1,045,190) $ 50.65 (48,455) $ 26.90 Canceled/Forfeited (2,042,804) $ 36.14 — $ — Outstanding as of December 31, 2020 8,663,084 $ 28.43 184,660 $ 28.42 |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | Share-Based Compensation Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Total share-based compensation cost $ 6 $ 9 $ 42 $ 57 Related income tax benefit $ 2 $ (3) $ 7 $ 8 Total intrinsic value of options exercised $ — $ 1 $ — $ 8 Tax benefits from exercised stock options and awards $ 1 $ 3 $ 5 $ 13 |
Cash Flows (Tables)
Cash Flows (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Supplemental Cash Flow Elements [Abstract] | |
Cash Payments for Interest on Indebtedness and for Taxes | Cash payments for interest on indebtedness and income taxes and other select non-cash activities are as follows: Nine Months Ended (in millions) December 31, 2020 December 31, 2019 Cash paid for: Interest $ 262 $ 277 Taxes on income, net of refunds (1) $ 159 $ 202 Non-cash activities: Operating: ROU assets obtained in exchange for lease, net (2) $ 449 $ 314 Prepaid assets acquired under long-term financing $ 46 $ 23 Investing: Capital expenditures in accounts payable and accrued expenses $ 16 $ 121 Capital expenditures through finance lease obligations $ 277 $ 507 Assets acquired under long-term financing $ 26 $ 282 (Decrease) increase in deferred purchase price receivable $ (52) $ 58 Contingent consideration $ 2 $ 19 Financing: Dividends declared but not yet paid $ — $ 54 (1) Income tax refunds were $31 million and $36 million for the nine months ended December 31, 2020 and December 31, 2019, respectively. (2) Net of $87 million change in lease classification from operating to finance lease in fiscal 2020. |
Segment Information (Tables)
Segment Information (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Segment Reporting [Abstract] | |
Operating Results by Reportable Segment | The following table summarizes operating results regularly provided to the CODM by reportable segment and a reconciliation to the financial statements: (in millions) GBS GIS Total Reportable Segments All Other Totals Three Months Ended December 31, 2020 Revenues $ 1,921 $ 2,367 $ 4,288 $ — $ 4,288 Segment profit $ 273 $ 88 $ 361 $ (61) $ 300 Depreciation and amortization (1) $ 53 $ 281 $ 334 $ 27 $ 361 Three Months Ended December 31, 2019 Revenues $ 2,359 $ 2,662 $ 5,021 $ — $ 5,021 Segment profit $ 353 $ 232 $ 585 $ (57) $ 528 Depreciation and amortization (1) $ 61 $ 244 $ 305 $ 28 $ 333 (in millions) GBS GIS Total Reportable Segments All Other Totals Nine Months Ended December 31, 2020 Revenues $ 6,337 $ 7,007 $ 13,344 $ — $ 13,344 Segment profit $ 805 $ 147 $ 952 $ (179) $ 773 Depreciation and amortization (1) $ 162 $ 839 $ 1,001 $ 77 $ 1,078 Nine Months Ended December 31, 2019 Revenues $ 6,803 $ 7,959 $ 14,762 $ — $ 14,762 Segment profit $ 1,078 $ 815 $ 1,893 $ (184) $ 1,709 Depreciation and amortization (1) $ 128 $ 771 $ 899 $ 82 $ 981 (1) Depreciation and amortization as presented excludes amortization of acquired intangible assets of $114 million and $146 million for the three months ended December 31, 2020 and 2019, respectively, and $414 million and $435 million for the nine months ended December 31, 2020 and 2019, respectively. |
Reconciliation of Consolidated Operating Income to Income Before Taxes | Three Months Ended Nine Months Ended (in millions) December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Profit Total profit for reportable segments $ 361 $ 585 952 $ 1,893 All other loss (61) (57) (179) (184) Interest income 28 33 76 130 Interest expense (82) (93) (284) (288) Restructuring costs (104) (74) (441) (248) Transaction, separation and integration-related costs (96) (68) (307) (226) Amortization of acquired intangible assets (114) (146) (414) (435) Gain on disposition of businesses 2,046 — 2,046 — Pension and OPEB actuarial and settlement losses — — (2) — Goodwill impairment losses — (53) — (2,940) Gain on arbitration award — — — 632 Income (loss) before income taxes $ 1,978 $ 127 $ 1,447 $ (1,666) |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 9 Months Ended |
Dec. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Long-term Purchase Agreements | Minimum purchase commitments as of December 31, 2020 were as follows: Fiscal year Minimum Purchase Commitment (1) (in millions) Remainder of 2021 $ 1,339 2022 1,093 2023 817 2024 227 Total $ 3,476 (1) A portion of the minimum purchase commitments for fiscal 2021 relates to the amounts committed under the HPE preferred vendor agreements. |
Schedule of Expiration of Financial Guarantees and Stand-by Letters of Credit Outstanding | The following table summarizes the expiration of the Company’s financial guarantees and stand-by letters of credit outstanding as of December 31, 2020: (in millions) Remainder of Fiscal 2021 Fiscal 2022 Fiscal 2023 and Thereafter Totals Surety bonds $ 14 $ 93 $ 87 $ 194 Letters of credit 37 147 527 711 Stand-by letters of credit 36 41 31 108 Totals $ 87 $ 281 $ 645 $ 1,013 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies - Narrative (Details) € in Millions, $ in Millions | 6 Months Ended | ||
Mar. 31, 2021EUR (€) | Mar. 31, 2021USD ($) | Oct. 01, 2020USD ($) | |
HHS Business | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Transaction consideration | $ 5,000 | ||
HPS Business | Forecast | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Amount of cash consideration received | € 459 | $ 525 |
Acquisitions - Luxoft, Narrativ
Acquisitions - Luxoft, Narrative (Details) - Luxoft Holding Inc. $ in Billions | Jun. 14, 2019USD ($) |
Business Acquisition [Line Items] | |
Total consideration transferred | $ 2 |
Percentage of business acquired | 100.00% |
Acquisitions - Luxoft Acquisiti
Acquisitions - Luxoft Acquisition, Purchase Price Allocation (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Mar. 31, 2020 | Jun. 14, 2019 |
Business Acquisition [Line Items] | |||
Goodwill | $ 736 | $ 2,017 | |
Luxoft Holding Inc. | |||
Business Acquisition [Line Items] | |||
Cash and cash equivalents | $ 113 | ||
Accounts receivable | 233 | ||
Other current assets | 15 | ||
Total current assets | 361 | ||
Property and equipment | 31 | ||
Intangible assets | 577 | ||
Other assets | 99 | ||
Total assets acquired | 1,068 | ||
Accounts payable, accrued payroll, accrued expenses, and other current liabilities | (121) | ||
Deferred revenue | (8) | ||
Long-term deferred tax liabilities and income tax payable | (106) | ||
Other liabilities | (72) | ||
Total liabilities assumed | (307) | ||
Net identifiable assets acquired | 761 | ||
Goodwill | 1,262 | ||
Total consideration transferred | $ 2,023 |
Acquisitions - Luxoft, Intangib
Acquisitions - Luxoft, Intangible Assets (Details) - Luxoft Holding Inc. | Jun. 14, 2019 |
Customer related intangibles | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Lives (Years) | 10 years |
Trade names | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Lives (Years) | 20 years |
Developed technology | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Lives (Years) | 3 years |
Third-party purchased software | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Estimated Useful Lives (Years) | 3 years |
Divestitures - Narrative (Detai
Divestitures - Narrative (Details) € in Millions, £ in Millions, $ in Millions, $ in Millions | Oct. 01, 2020USD ($) | Oct. 31, 2020USD ($) | Oct. 31, 2020GBP (£) | Oct. 31, 2020AUD ($) | Oct. 31, 2020EUR (€) | Dec. 31, 2020USD ($) | Jun. 30, 2020USD ($) | Jun. 30, 2020AUD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Gain on disposition of businesses | $ 2,046 | $ 0 | $ 2,046 | $ 0 | |||||||
Repayments of debt | $ 3,500 | 2,926 | $ 1,029 | ||||||||
Commercial paper | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Repayments of debt | 772 | £ 600 | |||||||||
Term loan | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Repayments of debt | 1,441 | ||||||||||
Term loan | Term Loan Payable, EUR, Due 2023-2024 | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Repayments of debt | 410 | € 350 | |||||||||
Term loan | Term Loan Payable, USD, Due 2025 | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Repayments of debt | 381 | $ 100 | |||||||||
Term loan | Term Loan Payable, AUD, Due 2022 | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Repayments of debt | 358 | $ 500 | $ 300 | ||||||||
Term loan | Term Loan Payable, EUR, Due 2022-2023 | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Repayments of debt | 292 | € 250 | |||||||||
Revolving credit facility | Line of Credit | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Repayments of debt | $ 1,250 | $ 4,000 | |||||||||
HHS Business | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Transaction consideration | $ 5,000 | ||||||||||
Portion of consideration related to future services to be provided | 85 | ||||||||||
Gain on disposition of businesses | $ 2,041 | ||||||||||
HHS Business | Milano Purchasers | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Commercial accounts receivable transferred | 272 | ||||||||||
Prepaid maintenance transferred | 12 | ||||||||||
Software licenses transferred | 48 | ||||||||||
Individually Insignificant Disposal Group | |||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
Gain on disposition of businesses | $ 5 |
Divestitures - Schedule of Asse
Divestitures - Schedule of Assets and Liabilities Held for Sale (Details) - HHS Business - Discontinued Operations, Disposed of by Sale $ in Millions | Dec. 31, 2020USD ($) |
Assets: | |
Cash and cash equivalents | $ 8 |
Accounts receivable, net | 295 |
Prepaid expenses | 39 |
Other current assets | 2 |
Total current assets | 344 |
Intangible assets, net | 1,308 |
Operating right-of-use assets, net | 74 |
Goodwill | 1,354 |
Property and equipment, net | 46 |
Other assets | 54 |
Total non-current assets | 2,836 |
Total assets | 3,180 |
Liabilities: | |
Accounts payable | 79 |
Accrued payroll and related costs | 13 |
Current operating lease liabilities | 27 |
Accrued expenses and other current liabilities | 36 |
Deferred revenue and advance contract payments | 20 |
Total current liabilities | 175 |
Non-current deferred revenue | 32 |
Long-term operating lease liabilities | 48 |
Other long term liabilities | 2 |
Total long-term liabilities | 82 |
Total liabilities | $ 257 |
Earnings (Loss) per Share - Sch
Earnings (Loss) per Share - Schedule of Earnings (Loss) per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Net Income (Loss) Attributable to Parent [Abstract] | ||||
Net income (loss) attributable to DXC common shareholders: | $ 1,098 | $ 82 | $ 649 | $ (1,874) |
Common share information: | ||||
Weighted average common shares outstanding for basic and diluted net (loss) EPS (in shares) | 254,320 | 255,090 | 254,030 | 260,240 |
Dilutive effect of stock options and equity awards (in shares) | 1,430 | 960 | 1,170 | 0 |
Weighted Average Number of Shares Outstanding, Diluted | 255,750 | 256,050 | 255,200 | 260,240 |
Earnings (loss) per share: | ||||
Basic (in dollars per share) | $ 4.32 | $ 0.32 | $ 2.55 | $ (7.20) |
Diluted (in dollars per share) | $ 4.29 | $ 0.32 | $ 2.54 | $ (7.20) |
Earnings (Loss) per Share - S_2
Earnings (Loss) per Share - Schedule of Antidilutive Securities (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Stock Options | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Anti-dilutive securities excluded from computation of diluted EPS (in shares) | 1,519,611 | 621,028 | 1,582,568 | 818,490 |
Restricted Stock Units | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Anti-dilutive securities excluded from computation of diluted EPS (in shares) | 1,418,752 | 2,125,734 | 1,628,968 | 2,116,898 |
Performance-based Restricted Stock Units | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Anti-dilutive securities excluded from computation of diluted EPS (in shares) | 836,866 | 0 | 723,754 | 351,410 |
Receivables - Narrative (Detail
Receivables - Narrative (Details) | 9 Months Ended | |||||
Dec. 31, 2020USD ($)extension | Dec. 31, 2020EUR (€)extension | Sep. 30, 2020USD ($) | Mar. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Mar. 31, 2019USD ($) | |
Purchasers | ||||||
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale [Line Items] | ||||||
Receivables facility, amount | $ 500,000,000 | $ 600,000,000 | ||||
Deferred purchase price for receivables | 0 | $ 0 | $ 574,000,000 | |||
Availability under receivable facility | 403,000,000 | |||||
Drawn amount | 407,000,000 | |||||
Liability for excess cash proceeds | $ 4,000,000 | |||||
Number of extensions | extension | 1 | 1 | ||||
Extension term | 1 year | |||||
Gain (loss) on sale of receivables | $ 0 | |||||
DE Purchasers | ||||||
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale [Line Items] | ||||||
Receivables facility, amount | 175,000,000 | € 150,000,000 | $ 102,000,000 | |||
Deferred purchase price for receivables | 0 | $ 103,000,000 | ||||
Availability under receivable facility | 123,000,000 | |||||
Drawn amount | $ 136,000,000 | |||||
Number of extensions | extension | 1 | 1 | ||||
Extension term | 1 year | |||||
Liability within accounts payable | $ 13,000,000 |
Receivables - Schedule of DFP (
Receivables - Schedule of DFP (Details) - USD ($) | 9 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Purchasers | ||
Transfer of Financial Assets Accounted for as Sales, Deferred Purchase Price [Roll Forward] | ||
Beginning balance | $ 574,000,000 | |
Transfers of receivables | 1,214,000,000 | |
Collections | (1,265,000,000) | |
Change in funding availability | 2,000,000 | |
Facility amendments | (525,000,000) | |
Ending balance | $ 0 | $ 0 |
DE Purchasers | ||
Transfer of Financial Assets Accounted for as Sales, Deferred Purchase Price [Roll Forward] | ||
Beginning balance | 103,000,000 | |
Transfers of receivables | 417,000,000 | |
Collections | (420,000,000) | |
Change in funding availability | 2,000,000 | |
Facility amendments | (102,000,000) | |
Ending balance | $ 0 |
Receivables - Allowance for Dou
Receivables - Allowance for Doubtful Accounts (Details) - USD ($) $ in Millions | 9 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | ||
Beginning balance | $ 74 | |
Provision for losses on accounts receivable | 52 | $ 0 |
Other adjustments to allowance and write-off's | 69 | |
Ending balance | 199 | |
Cumulative Effect, Period of Adoption, Adjustment | ||
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | ||
Beginning balance | $ 4 |
Leases - Narrative (Details)
Leases - Narrative (Details) | 9 Months Ended |
Dec. 31, 2020 | |
Lessee, Lease, Description [Line Items] | |
Extension term | 10 years |
Minimum | |
Lessee, Lease, Description [Line Items] | |
Remaining lease term | 1 year |
Termination term | 1 year |
Maximum | |
Lessee, Lease, Description [Line Items] | |
Remaining lease term | 12 years |
Termination term | 3 years |
Leases - Components of Lease Ex
Leases - Components of Lease Expense (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Leases [Abstract] | ||||
Operating lease cost | $ 156 | $ 166 | $ 463 | $ 506 |
Short-term lease cost | 14 | 17 | 40 | 41 |
Variable lease cost | 17 | 9 | 40 | 35 |
Sublease income | (10) | (9) | (32) | (28) |
Total operating costs | 177 | 183 | 511 | 554 |
Finance lease cost: | ||||
Amortization of right-of-use assets | 107 | 90 | 322 | 339 |
Interest on lease liabilities | 10 | 16 | 35 | 50 |
Total finance lease cost | $ 117 | $ 106 | $ 357 | $ 389 |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions | 9 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Cash paid for amounts included in the measurement of: | ||
Operating cash flows used in operating leases | $ 463 | $ 506 |
Operating cash flows used in finance leases | 35 | 50 |
Financing cash flows used in finance leases | $ 430 | $ 436 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Mar. 31, 2020 |
Assets: | ||
ROU operating lease assets | $ 1,459 | $ 1,428 |
ROU finance lease assets | 971 | 1,220 |
Total | 2,430 | 2,648 |
Current | ||
Operating lease | 450 | 482 |
Finance lease | 431 | 444 |
Total | 881 | 926 |
Non-current | ||
Operating lease | 1,113 | 1,063 |
Finance lease | 545 | 602 |
Total | $ 1,658 | $ 1,665 |
Weighted Average remaining lease term: | ||
Operating leases | 4 years 9 months 18 days | 4 years 9 months 18 days |
Finance leases | 2 years 8 months 12 days | 2 years 8 months 12 days |
Weighted average remaining discount rate: | ||
Operating leases | 4.00% | 4.00% |
Finance leases | 3.80% | 6.40% |
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization | us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization |
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] | us-gaap:DebtCurrent | us-gaap:DebtCurrent |
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] | us-gaap:LongTermDebtNoncurrent | us-gaap:LongTermDebtNoncurrent |
Leases - Maturities of Lease Li
Leases - Maturities of Lease Liabilities, Topic 842 (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Mar. 31, 2020 |
Finance Leases | ||
Remainder of 2021 | $ 128 | |
2022 | 419 | |
2023 | 275 | |
2024 | 139 | |
2025 | 48 | |
Thereafter | 6 | |
Total lease payments | 1,015 | |
Less: imputed interest | (39) | |
Total payments | 976 | $ 1,046 |
Real Estate | ||
Operating Leases | ||
Remainder of 2021 | 117 | |
2022 | 412 | |
2023 | 337 | |
2024 | 262 | |
2025 | 192 | |
Thereafter | 297 | |
Total lease payments | 1,617 | |
Less: imputed interest | (151) | |
Total payments | 1,466 | |
Equipment | ||
Operating Leases | ||
Remainder of 2021 | 15 | |
2022 | 42 | |
2023 | 24 | |
2024 | 11 | |
2025 | 5 | |
Thereafter | 3 | |
Total lease payments | 100 | |
Less: imputed interest | (3) | |
Total payments | $ 97 |
Fair Value - Fair Value Measure
Fair Value - Fair Value Measurements on a Recurring Basis (Details) - Recurring - USD ($) $ in Millions | Dec. 31, 2020 | Mar. 31, 2020 |
Assets: | ||
Other debt securities | $ 62 | $ 51 |
Deferred purchase price receivable | 103 | |
Total assets | 923 | 905 |
Liabilities: | ||
Contingent consideration | 40 | 46 |
Total liabilities | 40 | 46 |
Level 1 | ||
Assets: | ||
Other debt securities | 0 | 0 |
Deferred purchase price receivable | 0 | |
Total assets | 861 | 751 |
Liabilities: | ||
Contingent consideration | 0 | 0 |
Total liabilities | 0 | 0 |
Level 2 | ||
Assets: | ||
Other debt securities | 59 | 48 |
Deferred purchase price receivable | 0 | |
Total assets | 59 | 48 |
Liabilities: | ||
Contingent consideration | 0 | 0 |
Total liabilities | 0 | 0 |
Cost basis | 59 | 37 |
Unrealized gains | 0 | 11 |
Level 2 | Other Income, Net | ||
Liabilities: | ||
Unrealized gains | 17 | |
Level 3 | ||
Assets: | ||
Other debt securities | 3 | 3 |
Deferred purchase price receivable | 103 | |
Total assets | 3 | 106 |
Liabilities: | ||
Contingent consideration | 40 | 46 |
Total liabilities | 40 | 46 |
Money market funds and money market deposit accounts | ||
Assets: | ||
Cash and cash equivalents | 262 | 156 |
Money market funds and money market deposit accounts | Level 1 | ||
Assets: | ||
Cash and cash equivalents | 262 | 156 |
Money market funds and money market deposit accounts | Level 2 | ||
Assets: | ||
Cash and cash equivalents | 0 | 0 |
Money market funds and money market deposit accounts | Level 3 | ||
Assets: | ||
Cash and cash equivalents | 0 | 0 |
U.S. treasury bills | ||
Assets: | ||
Cash and cash equivalents | 250 | |
U.S. treasury bills | Level 1 | ||
Assets: | ||
Cash and cash equivalents | 250 | |
U.S. treasury bills | Level 2 | ||
Assets: | ||
Cash and cash equivalents | 0 | |
U.S. treasury bills | Level 3 | ||
Assets: | ||
Cash and cash equivalents | 0 | |
Time deposits | ||
Assets: | ||
Cash and cash equivalents | 349 | 595 |
Time deposits | Level 1 | ||
Assets: | ||
Cash and cash equivalents | 349 | 595 |
Time deposits | Level 2 | ||
Assets: | ||
Cash and cash equivalents | 0 | 0 |
Time deposits | Level 3 | ||
Assets: | ||
Cash and cash equivalents | $ 0 | $ 0 |
Fair Value - Other Fair Value D
Fair Value - Other Fair Value Disclosures (Details) - USD ($) $ in Millions | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Mar. 31, 2020 | |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Long-term debt, net of current maturities | $ 5,444 | $ 8,672 | |
Tangible asset impairment charges | 0 | $ 0 | |
Impairment of intangible assets | 0 | 0 | |
Impairment of other intangible assets | 0 | $ 0 | |
Fair value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Long-term debt, net of current maturities | 5,500 | 8,200 | |
Carrying value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Long-term debt, net of current maturities | $ 5,200 | $ 8,400 |
Derivative and Hedging Activi_3
Derivative and Hedging Activities - Narrative (Details) $ in Millions | 3 Months Ended | 9 Months Ended | |||
Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2020USD ($)counterparty | Dec. 31, 2019USD ($) | Mar. 31, 2020USD ($) | |
Derivative [Line Items] | |||||
Foreign currency cash flow hedge gain (loss) to be reclassified during next 12 months | $ 2 | $ 2 | |||
Number of counterparties with concentration of credit risk | counterparty | 7 | ||||
Designated as Hedging Instrument | Cash Flow Hedging | Foreign currency forward contracts | |||||
Derivative [Line Items] | |||||
Notational amount of derivative | 507 | $ 507 | $ 455 | ||
Designated as Hedging Instrument | Net Investment Hedging | |||||
Derivative [Line Items] | |||||
Pretax gain (loss) on derivative instruments | 0 | $ 0 | (6) | $ 18 | |
Designated as Hedging Instrument | Net Investment Hedging | Foreign currency denominated debt | |||||
Derivative [Line Items] | |||||
Notational amount of derivative | 800 | 800 | 1,900 | ||
Pretax gain (loss) on derivatives designated for hedge accounting included other comprehensive loss | (36) | (125) | |||
Not Designated as Hedging Instrument | Foreign currency forward contracts | |||||
Derivative [Line Items] | |||||
Notational amount of derivative | $ 1,700 | $ 1,700 | $ 2,200 |
Derivative and Hedging Activi_4
Derivative and Hedging Activities - Nondesignated Hedging (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Other expense (income), net | Foreign currency forward contracts | Not Designated as Hedging Instrument | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Pretax loss (gain) on derivative instruments | $ 16 | $ 1 | $ 74 | $ (21) |
Derivative and Hedging Activi_5
Derivative and Hedging Activities - Fair Value (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Mar. 31, 2020 |
Designated as Hedging Instrument | Fair Value Hedging | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | $ 9 | $ 0 |
Derivative liability, fair value | 5 | 20 |
Designated as Hedging Instrument | Fair Value Hedging | Foreign currency forward contracts | Other current assets | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 9 | 0 |
Designated as Hedging Instrument | Fair Value Hedging | Foreign currency forward contracts | Accrued expenses and other current liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, fair value | 5 | 20 |
Not Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 6 | 16 |
Derivative liability, fair value | 17 | 12 |
Not Designated as Hedging Instrument | Foreign currency forward contracts | Other current assets | ||
Derivatives, Fair Value [Line Items] | ||
Derivative asset, fair value | 6 | 16 |
Not Designated as Hedging Instrument | Foreign currency forward contracts | Accrued expenses and other current liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liability, fair value | $ 17 | $ 12 |
Intangible Assets - Summary of
Intangible Assets - Summary of Intangible Assets (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Mar. 31, 2020 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | $ 8,564 | $ 10,078 |
Accumulated Amortization | 4,545 | 4,347 |
Net Carrying Value | 4,019 | 5,731 |
Software | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 4,001 | 4,048 |
Accumulated Amortization | 2,891 | 2,614 |
Net Carrying Value | 1,110 | 1,434 |
Customer related intangible assets | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 4,296 | 5,795 |
Accumulated Amortization | 1,606 | 1,697 |
Net Carrying Value | 2,690 | 4,098 |
Other intangible assets | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 267 | 235 |
Accumulated Amortization | 48 | 36 |
Net Carrying Value | $ 219 | $ 199 |
Intangible Assets - Components
Intangible Assets - Components of Amortization Expense (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Finite-Lived Intangible Assets [Line Items] | ||||
Amortization expense | $ 290 | $ 343 | $ 929 | $ 944 |
Intangible asset amortization | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Amortization expense | 224 | 272 | 735 | 747 |
Transition and transformation contract cost amortization | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Amortization expense | $ 66 | $ 71 | $ 194 | $ 197 |
Intangible Assets - Estimated F
Intangible Assets - Estimated Future Amortization (Details) $ in Millions | Dec. 31, 2020USD ($) |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Remainder of 2021 | $ 236 |
2022 | 821 |
2023 | 740 |
2024 | 650 |
2025 | $ 535 |
Goodwill (Details)
Goodwill (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Changes in the carrying amount of goodwill by segment [Roll Forward] | ||||
Goodwill, gross | $ 11,573 | |||
Accumulated impairment losses | (9,556) | |||
Balance as of March 31, 2020, net | 2,017 | |||
Acquisition related adjustments | 18 | |||
Divestitures | (1,355) | |||
Assets held for sale | (4) | |||
Foreign currency translation | 60 | |||
Goodwill, gross | $ 10,292 | 10,292 | ||
Accumulated impairment losses | (9,556) | (9,556) | ||
Balance as of December 31, 2020, net | 736 | 736 | ||
Goodwill impairment losses | 0 | $ 53 | 0 | $ 2,940 |
GBS | ||||
Changes in the carrying amount of goodwill by segment [Roll Forward] | ||||
Goodwill, gross | 6,507 | |||
Accumulated impairment losses | (4,490) | |||
Balance as of March 31, 2020, net | 2,017 | |||
Acquisition related adjustments | 18 | |||
Divestitures | (1,355) | |||
Assets held for sale | (4) | |||
Foreign currency translation | 60 | |||
Goodwill, gross | 5,226 | 5,226 | ||
Accumulated impairment losses | (4,490) | (4,490) | ||
Balance as of December 31, 2020, net | 736 | 736 | ||
GIS | ||||
Changes in the carrying amount of goodwill by segment [Roll Forward] | ||||
Goodwill, gross | 5,066 | |||
Accumulated impairment losses | (5,066) | |||
Balance as of March 31, 2020, net | 0 | |||
Acquisition related adjustments | 0 | |||
Divestitures | 0 | |||
Assets held for sale | 0 | |||
Foreign currency translation | 0 | |||
Goodwill, gross | 5,066 | 5,066 | ||
Accumulated impairment losses | (5,066) | (5,066) | ||
Balance as of December 31, 2020, net | $ 0 | $ 0 |
Debt - Schedule of Debt (Detail
Debt - Schedule of Debt (Details) | 9 Months Ended | ||||
Dec. 31, 2020USD ($) | Dec. 31, 2020EUR (€) | Dec. 31, 2020GBP (£) | Sep. 30, 2020USD ($) | Mar. 31, 2020USD ($) | |
Short-term debt and current maturities of long-term debt | |||||
Euro-denominated commercial paper | $ 112,000,000 | $ 542,000,000 | |||
Current maturities of long-term debt | 252,000,000 | 290,000,000 | |||
Current maturities of finance lease liabilities | 431,000,000 | 444,000,000 | |||
Short-term debt and current maturities of long-term debt | 795,000,000 | 1,276,000,000 | |||
Long-term debt, net of current maturities | |||||
Finance lease liabilities | 976,000,000 | 1,046,000,000 | |||
Long-term debt | 6,127,000,000 | 9,406,000,000 | |||
Less: current maturities | 683,000,000 | 734,000,000 | |||
Long-term debt, net of current maturities | 5,444,000,000 | 8,672,000,000 | |||
Term loan | Term Loan Payable, AUD, Due 2022 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | 0 | 489,000,000 | |||
Term loan | Term Loan Payable, GBP, Due 2022 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | 0 | 556,000,000 | |||
Term loan | Term Loan Payable, EUR, Due 2022-2023 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 0 | 822,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 0.65% | 0.65% | 0.65% | ||
Term loan | Term Loan Payable, EUR, Due 2023-2024 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 488,000,000 | 821,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 0.80% | 0.80% | 0.80% | ||
Term loan | Term Loan Payable, USD, Due 2025 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 0 | 480,000,000 | |||
Senior notes | Senior notes due 2023 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 276,000,000 | 276,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 4.45% | 4.45% | 4.45% | ||
Face amount | $ 274,000,000 | ||||
Senior notes | Senior notes due 2023 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 172,000,000 | 172,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 4.45% | 4.45% | 4.45% | ||
Face amount | $ 171,000,000 | ||||
Senior notes | Senior notes due 2025 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 504,000,000 | 505,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 4.25% | 4.25% | 4.25% | ||
Face amount | $ 500,000,000 | ||||
Senior notes | Senior Notes, Due 2024 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 497,000,000 | 0 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 4.00% | 4.00% | 4.00% | 4.00% | |
Face amount | $ 500,000,000 | $ 500,000,000 | |||
Senior notes | Senior Notes, Due 2026 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 496,000,000 | 0 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 4.13% | 4.13% | 4.13% | 4.13% | |
Face amount | $ 500,000,000 | $ 500,000,000 | |||
Senior notes | Senior notes due 2025 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 339,000,000 | 307,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 2.75% | 2.75% | 2.75% | ||
Face amount | £ | £ 250,000,000 | ||||
Senior notes | Senior notes due 2026 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 792,000,000 | 709,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 1.75% | 1.75% | 1.75% | ||
Face amount | € | € 650,000,000 | ||||
Senior notes | Senior notes due 2028 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 507,000,000 | 507,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 4.75% | 4.75% | 4.75% | ||
Face amount | $ 500,000,000 | ||||
Senior notes | Senior notes due 2030 | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 269,000,000 | 271,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 7.45% | 7.45% | 7.45% | ||
Face amount | $ 234,000,000 | ||||
Secured debt | Lease credit facility | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | 0 | 11,000,000 | |||
Borrowings for assets acquired under long-term financing | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | 742,000,000 | 802,000,000 | |||
Mandatorily redeemable preferred stock outstanding | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 63,000,000 | 62,000,000 | |||
Debt Information [Abstract] | |||||
Effective interest rate | 6.00% | 6.00% | 6.00% | ||
Other borrowings | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 6,000,000 | 70,000,000 | |||
Minimum | Term loan | Term Loan Payable, AUD, Due 2022 | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 0.94% | 0.94% | 0.94% | ||
Minimum | Term loan | Term Loan Payable, GBP, Due 2022 | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 0.88% | 0.88% | 0.88% | ||
Minimum | Term loan | Term Loan Payable, USD, Due 2025 | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 1.40% | 1.40% | 1.40% | ||
Minimum | Secured debt | Lease credit facility | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 1.15% | 1.15% | 1.15% | ||
Minimum | Finance lease liabilities | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 0.62% | 0.62% | 0.62% | ||
Minimum | Borrowings for assets acquired under long-term financing | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 0.00% | 0.00% | 0.00% | ||
Maximum | Term loan | Term Loan Payable, AUD, Due 2022 | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 0.96% | 0.96% | 0.96% | ||
Maximum | Term loan | Term Loan Payable, GBP, Due 2022 | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 1.46% | 1.46% | 1.46% | ||
Maximum | Term loan | Term Loan Payable, USD, Due 2025 | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 2.24% | 2.24% | 2.24% | ||
Maximum | Secured debt | Lease credit facility | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 1.99% | 1.99% | 1.99% | ||
Maximum | Finance lease liabilities | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 18.47% | 18.47% | 18.47% | ||
Maximum | Borrowings for assets acquired under long-term financing | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 6.39% | 6.39% | 6.39% | ||
EURIBOR | Minimum | Term loan | Term Loan Payable, EUR, Due 2023-2024 | |||||
Debt Information [Abstract] | |||||
Basis spread on variable rate | 0.55% | ||||
EURIBOR | Maximum | Term loan | Term Loan Payable, EUR, Due 2023-2024 | |||||
Debt Information [Abstract] | |||||
Basis spread on variable rate | 1.05% | ||||
Commercial paper | |||||
Debt Information [Abstract] | |||||
Maximum borrowing capacity | € | € 1,000,000,000 | ||||
Commercial paper | Minimum | |||||
Debt Information [Abstract] | |||||
Weighted average interest rate, short- term debt | (0.22%) | (0.22%) | (0.22%) | ||
Commercial paper | Maximum | |||||
Debt Information [Abstract] | |||||
Weighted average interest rate, short- term debt | 0.44% | 0.44% | 0.44% | ||
Finance Lease Liabilities | Minimum | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 0.62% | 0.62% | 0.62% | ||
Finance Lease Liabilities | Maximum | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 18.47% | 18.47% | 18.47% | ||
Revolving credit facility | Line of Credit | |||||
Long-term debt, net of current maturities | |||||
Long-term debt | $ 0 | $ 1,500,000,000 | |||
Debt Information [Abstract] | |||||
Maximum borrowing capacity | $ 4,000,000,000 | ||||
Revolving credit facility | Minimum | Line of Credit | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 1.26% | 1.26% | 1.26% | ||
Revolving credit facility | Maximum | Line of Credit | |||||
Debt Information [Abstract] | |||||
Effective interest rate | 2.08% | 2.08% | 2.08% |
Debt - Narrative (Details)
Debt - Narrative (Details) $ in Millions | 1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||||||
Oct. 31, 2020USD ($) | Oct. 31, 2020GBP (£) | Oct. 31, 2020AUD ($) | Oct. 31, 2020EUR (€) | Dec. 31, 2020USD ($) | Sep. 30, 2020USD ($) | Sep. 30, 2020GBP (£) | Jun. 30, 2020USD ($) | Jun. 30, 2020GBP (£) | Jun. 30, 2020AUD ($) | Jun. 30, 2020EUR (€) | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2020GBP (£) | Dec. 31, 2020EUR (€) | |
Debt Instrument [Line Items] | |||||||||||||||
Repayments of debt | $ 3,500,000,000 | $ 2,926,000,000 | $ 1,029,000,000 | ||||||||||||
Commercial paper | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Maximum borrowing capacity | € | € 1,000,000,000 | ||||||||||||||
Repayments of debt | 772,000,000 | £ 600,000,000 | |||||||||||||
Senior notes | Senior Notes Due 2024 and 2026 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Principal amount | $ 1,000,000,000 | ||||||||||||||
Senior notes | Senior Notes, Due 2024 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Principal amount | $ 500,000,000 | $ 500,000,000 | $ 500,000,000 | ||||||||||||
Effective interest rate | 4.00% | 4.00% | 4.00% | 4.00% | 4.00% | ||||||||||
Senior notes | Senior Notes, Due 2026 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Principal amount | $ 500,000,000 | $ 500,000,000 | $ 500,000,000 | ||||||||||||
Effective interest rate | 4.13% | 4.13% | 4.13% | 4.13% | 4.13% | ||||||||||
Senior notes | Senior notes due 2025 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Principal amount | £ | £ 250,000,000 | ||||||||||||||
Effective interest rate | 2.75% | 2.75% | 2.75% | 2.75% | |||||||||||
Senior notes | Senior notes due 2026 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Principal amount | € | € 650,000,000 | ||||||||||||||
Effective interest rate | 1.75% | 1.75% | 1.75% | 1.75% | |||||||||||
Term loan | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Repayments of debt | $ 1,441,000,000 | ||||||||||||||
Term loan | Term Loan Payable, EUR, Due 2023 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Repayments of debt | € | € 500,000,000 | ||||||||||||||
Term loan | Term Loan Payable, EUR, Due 2022-2023 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Effective interest rate | 0.65% | 0.65% | 0.65% | 0.65% | |||||||||||
Repayments of debt | 292,000,000 | € 250,000,000 | |||||||||||||
Term loan | Term Loan Payable, GBP, Due 2022 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Repayments of debt | £ | £ 300,000,000 | £ 150,000,000 | |||||||||||||
Term loan | Term Loan Payable, AUD, Due 2022 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Repayments of debt | 358,000,000 | $ 500 | $ 300 | ||||||||||||
Term loan | Term Loan Payable, USD, Due 2025 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Repayments of debt | 381,000,000 | $ 100,000,000 | |||||||||||||
Term loan | Term Loan Payable, EUR, Due 2023-2024 | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Effective interest rate | 0.80% | 0.80% | 0.80% | 0.80% | |||||||||||
Repayments of debt | 410,000,000 | € 350,000,000 | |||||||||||||
Revolving credit facility | Line of Credit | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Proceeds from debt issuance | $ 2,500,000,000 | ||||||||||||||
Maximum borrowing capacity | $ 4,000,000,000 | $ 4,000,000,000 | |||||||||||||
Repayments of debt | $ 1,250,000,000 | $ 4,000,000,000 |
Revenue - Disaggregation of Rev
Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disaggregation of Revenue [Line Items] | ||||
Revenues | $ 4,288 | $ 5,021 | $ 13,344 | $ 14,762 |
United States | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 1,290 | 1,843 | 4,665 | 5,500 |
United Kingdom | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 607 | 707 | 1,759 | 2,100 |
Other Europe | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 1,335 | 1,329 | 3,784 | 3,819 |
Australia | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 377 | 380 | 1,128 | 1,119 |
Other International | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | $ 679 | $ 762 | $ 2,008 | $ 2,224 |
Revenue - Narrative (Details)
Revenue - Narrative (Details) $ in Billions | Dec. 31, 2020USD ($) |
Revenue from Contract with Customer [Abstract] | |
Remaining performance obligation | $ 24 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation percentage | 14.00% |
Remaining performance obligation period | 3 months |
Revenue - Contract Balances (De
Revenue - Contract Balances (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Mar. 31, 2019 |
Revenue from Contract with Customer [Abstract] | ||||
Trade receivables, net | $ 2,785 | $ 3,059 | ||
Contract assets | 418 | 454 | ||
Contract liabilities | $ 1,768 | $ 1,756 | $ 1,816 | $ 1,886 |
Revenue - Change in Contract Li
Revenue - Change in Contract Liabilities (Details) - USD ($) $ in Millions | 9 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Disaggregation of Revenue [Line Items] | ||
Balance, beginning of period | $ 1,756 | $ 1,886 |
Deferred revenue | 2,111 | 2,091 |
Recognition of deferred revenue | (2,137) | (2,137) |
Currency translation adjustment | 146 | 12 |
Other | (108) | (36) |
Balance, end of period | 1,768 | $ 1,816 |
HHS Business | ||
Disaggregation of Revenue [Line Items] | ||
Other | $ (54) |
Restructuring Costs (Details)
Restructuring Costs (Details) $ in Millions | Dec. 31, 2020USD ($) |
Restructuring Reserve [Abstract] | |
Accrued expenses and other current liabilities | $ 261 |
Other long-term liabilities | 60 |
Total | $ 321 |
Restructuring Costs - Narrative
Restructuring Costs - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring costs | $ 104 | $ 74 | $ 441 | $ 248 |
Fiscal 2020 Plan | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring costs | 3 | |||
Cost incurred to date | 295 | 295 | ||
Fiscal 2020 Plan | Employee Severance | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring costs | 7 | |||
Cost incurred to date | 278 | 278 | ||
Fiscal 2020 Plan | Facilities Costs | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring costs | (4) | |||
Cost incurred to date | 17 | 17 | ||
Fiscal 2019 Plan | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring costs | (5) | |||
Cost incurred to date | 477 | 477 | ||
Fiscal 2019 Plan | Employee Severance | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring costs | (2) | |||
Cost incurred to date | 336 | 336 | ||
Fiscal 2019 Plan | Facilities Costs | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring costs | (3) | |||
Cost incurred to date | 141 | 141 | ||
Fiscal 2018 Plan | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Cost incurred to date | 987 | 987 | ||
Fiscal 2018 Plan | Employee Severance | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Cost incurred to date | 791 | 791 | ||
Fiscal 2018 Plan | Facilities Costs | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Cost incurred to date | $ 196 | $ 196 |
Restructuring Costs - Restructu
Restructuring Costs - Restructuring Liability (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Mar. 31, 2020 | |
Restructuring Reserve [Roll Forward] | |||||
Costs Expensed, Net of Reversals | $ 104 | $ 74 | $ 441 | $ 248 | |
Restructuring Liability, ending balance | 321 | 321 | |||
Fiscal 2021 Plan | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 0 | ||||
Costs Expensed, Net of Reversals | 441 | ||||
Costs Not Affecting Restructuring Liability | (18) | ||||
Cash Paid | (221) | ||||
Other | 8 | ||||
Restructuring Liability, ending balance | 210 | 210 | $ 0 | ||
Fiscal 2021 Plan | Workforce Reductions | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 0 | ||||
Costs Expensed, Net of Reversals | 416 | ||||
Costs Not Affecting Restructuring Liability | (9) | ||||
Cash Paid | (210) | ||||
Other | 9 | ||||
Restructuring Liability, ending balance | 206 | 206 | 0 | ||
Fiscal 2021 Plan | Facilities Costs | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 0 | ||||
Costs Expensed, Net of Reversals | 25 | ||||
Costs Not Affecting Restructuring Liability | (9) | ||||
Cash Paid | (11) | ||||
Other | (1) | ||||
Restructuring Liability, ending balance | 4 | 4 | 0 | ||
Fiscal 2020 Plan | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 76 | ||||
Costs Expensed, Net of Reversals | 3 | ||||
Costs Not Affecting Restructuring Liability | 6 | ||||
Cash Paid | (51) | ||||
Other | 5 | ||||
Restructuring Liability, ending balance | 39 | 39 | 76 | ||
Costs expensed, net of reversals | 11 | ||||
Fiscal 2020 Plan | Workforce Reductions | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 74 | ||||
Costs Expensed, Net of Reversals | 7 | ||||
Costs Not Affecting Restructuring Liability | 2 | ||||
Cash Paid | (49) | ||||
Other | 5 | ||||
Restructuring Liability, ending balance | 39 | 39 | 74 | ||
Costs expensed, net of reversals | 14 | ||||
Fiscal 2020 Plan | Facilities Costs | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 2 | ||||
Costs Expensed, Net of Reversals | (4) | ||||
Costs Not Affecting Restructuring Liability | 4 | ||||
Cash Paid | (2) | ||||
Other | 0 | ||||
Restructuring Liability, ending balance | 0 | 0 | 2 | ||
Fiscal 2019 Plan | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 30 | ||||
Costs Expensed, Net of Reversals | (5) | ||||
Costs Not Affecting Restructuring Liability | (1) | ||||
Cash Paid | (13) | ||||
Other | 3 | ||||
Restructuring Liability, ending balance | 14 | 14 | 30 | ||
Costs expensed, net of reversals | 10 | ||||
Fiscal 2019 Plan | Workforce Reductions | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 25 | ||||
Costs Expensed, Net of Reversals | (2) | ||||
Costs Not Affecting Restructuring Liability | (3) | ||||
Cash Paid | (13) | ||||
Other | 2 | ||||
Restructuring Liability, ending balance | 9 | 9 | 25 | ||
Fiscal 2019 Plan | Facilities Costs | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 5 | ||||
Costs Expensed, Net of Reversals | (3) | ||||
Costs Not Affecting Restructuring Liability | 2 | ||||
Cash Paid | 0 | ||||
Other | 1 | ||||
Restructuring Liability, ending balance | 5 | 5 | 5 | ||
Other Prior Year Plans | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 24 | ||||
Costs Expensed, Net of Reversals | 1 | ||||
Costs Not Affecting Restructuring Liability | 2 | ||||
Cash Paid | (14) | ||||
Other | 2 | ||||
Restructuring Liability, ending balance | 15 | 15 | 24 | ||
Costs expensed, net of reversals | 3 | ||||
Other Prior Year Plans | Workforce Reductions | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 24 | ||||
Costs Expensed, Net of Reversals | 1 | ||||
Costs Not Affecting Restructuring Liability | 2 | ||||
Cash Paid | (14) | ||||
Other | 2 | ||||
Restructuring Liability, ending balance | 15 | 15 | 24 | ||
Other Prior Year Plans | Facilities Costs | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 0 | ||||
Costs Expensed, Net of Reversals | 0 | ||||
Costs Not Affecting Restructuring Liability | 0 | ||||
Cash Paid | 0 | ||||
Other | 0 | ||||
Restructuring Liability, ending balance | 0 | 0 | 0 | ||
Acquired Liabilities | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 50 | ||||
Costs Expensed, Net of Reversals | 1 | ||||
Costs Not Affecting Restructuring Liability | 1 | ||||
Cash Paid | (10) | ||||
Other | 1 | ||||
Restructuring Liability, ending balance | 43 | 43 | 50 | ||
Acquired Liabilities | Workforce Reductions | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 39 | ||||
Costs Expensed, Net of Reversals | 1 | ||||
Costs Not Affecting Restructuring Liability | 0 | ||||
Cash Paid | (7) | ||||
Other | 1 | ||||
Restructuring Liability, ending balance | 34 | 34 | 39 | ||
Acquired Liabilities | Facilities Costs | |||||
Restructuring Reserve [Roll Forward] | |||||
Restructuring Liability, beginning balance | 11 | ||||
Costs Expensed, Net of Reversals | 0 | ||||
Costs Not Affecting Restructuring Liability | 1 | ||||
Cash Paid | (3) | ||||
Other | 0 | ||||
Restructuring Liability, ending balance | $ 9 | $ 9 | $ 11 |
Pension and Other Benefit Pla_3
Pension and Other Benefit Plans - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||||
Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Mar. 31, 2020 | |
Defined Benefit Plan Disclosure [Line Items] | ||||||
Deferred compensation plan, liability | $ 45 | $ 45 | $ 48 | |||
Pension Plans, Defined Benefit | ||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Net loss from remeasurement of plan assets and liabilities | (80) | $ (80) | (229) | $ (219) | ||
Curtailment gain | 0 | 0 | 9 | 0 | ||
Recognition of actuarial loss | $ 0 | $ 0 | $ 11 | $ 0 | ||
Foreign Plan [Member] | Pension Plans, Defined Benefit | ||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Net loss from remeasurement of plan assets and liabilities | $ 2 | |||||
Curtailment gain | 9 | |||||
Recognition of actuarial loss | $ 11 | |||||
Directors | ||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Maximum deferral percentage | 100.00% |
Pension and Other Benefit Pla_4
Pension and Other Benefit Plans - Pension Plan, Net Periodic Costs and Other Changes (Details) - Pension Plans, Defined Benefit - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Defined Benefit Plan Disclosure [Line Items] | ||||
Service cost | $ 23 | $ 23 | $ 68 | $ 69 |
Interest cost | 62 | 60 | 181 | 177 |
Expected return on assets | (163) | (161) | (477) | (476) |
Amortization of prior service costs | (2) | (2) | (6) | (6) |
Contractual termination benefit | 0 | 0 | 3 | 17 |
Curtailment gain | 0 | 0 | (9) | 0 |
Recognition of actuarial loss | 0 | 0 | 11 | 0 |
Net periodic pension income | $ (80) | $ (80) | $ (229) | $ (219) |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Contingency [Line Items] | ||||
Effective income tax rate | 44.20% | 29.10% | 54.50% | (11.50%) |
Foreign earnings not indefinitely reinvested | $ 547 | $ 547 | ||
Potential federal and state tax cost | 410 | 410 | ||
Decrease in liability for uncertain tax positions | 13 | |||
Reasonably possible reduction in liability for uncertain tax positions | 37 | 37 | ||
HPES | ||||
Income Tax Contingency [Line Items] | ||||
Tax indemnification payable, net | 3 | 3 | ||
Tax indemnification receivable, uncertain tax positions | 48 | 48 | ||
Tax indemnification receivable, tax indemnification payable | 79 | 79 | ||
Tax indemnification payable | 130 | 130 | ||
Perspecta | ||||
Income Tax Contingency [Line Items] | ||||
Tax indemnification payable | 44 | 44 | ||
Tax indemnification receivable | $ 81 | $ 81 |
Stockholders' Equity - Share Re
Stockholders' Equity - Share Repurchases (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||||
Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Nov. 08, 2018 | Apr. 03, 2017 | |
Equity [Abstract] | |||||||
Initial authorization | $ 2,000,000,000 | ||||||
Additional authorization | $ 2,000,000,000 | ||||||
Equity, Class of Treasury Stock [Line Items] | |||||||
Number of shares repurchased (in shares) | 2,353,852 | 6,220,190 | 7,359,609 | 0 | 15,933,651 | ||
Average price per share (in dollars per share) | $ 36.68 | $ 40.18 | $ 54.35 | $ 46.21 | |||
Amount | $ 86,000,000 | $ 250,000,000 | $ 400,000,000 | $ 736,000,000 | |||
Open market purchases | |||||||
Equity, Class of Treasury Stock [Line Items] | |||||||
Number of shares repurchased (in shares) | 2,353,852 | 4,414,840 | 5,510,415 | ||||
Average price per share (in dollars per share) | $ 36.68 | $ 33.96 | $ 54.44 | ||||
Amount | $ 86,000,000 | $ 150,000,000 | $ 300,000,000 | ||||
Accelerated stock repurchases | |||||||
Equity, Class of Treasury Stock [Line Items] | |||||||
Number of shares repurchased (in shares) | 0 | 1,805,350 | 1,849,194 | ||||
Average price per share (in dollars per share) | $ 0 | $ 55.39 | $ 54.08 | ||||
Amount | $ 0 | $ 100,000,000 | $ 100,000,000 |
Stockholders' Equity - Accumula
Stockholders' Equity - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions | 9 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
AOCI Including Portion Attributable to Noncontrolling Interest [Abstract] | ||
Beginning balance | $ 5,129 | $ 11,725 |
Current-period other comprehensive income (loss) | 203 | 76 |
Amounts reclassified from accumulated other comprehensive loss | (7) | (8) |
Ending balance | 5,995 | 9,101 |
Foreign Currency Translation Adjustments | ||
AOCI Including Portion Attributable to Noncontrolling Interest [Abstract] | ||
Beginning balance | (851) | (517) |
Current-period other comprehensive income (loss) | 197 | 78 |
Amounts reclassified from accumulated other comprehensive loss | 0 | 0 |
Ending balance | (654) | (439) |
Cash Flow Hedges | ||
AOCI Including Portion Attributable to Noncontrolling Interest [Abstract] | ||
Beginning balance | (20) | (3) |
Current-period other comprehensive income (loss) | 12 | (4) |
Amounts reclassified from accumulated other comprehensive loss | 6 | (2) |
Ending balance | (2) | (9) |
Available-for-sale Securities | ||
AOCI Including Portion Attributable to Noncontrolling Interest [Abstract] | ||
Beginning balance | 9 | 9 |
Current-period other comprehensive income (loss) | (6) | 2 |
Amounts reclassified from accumulated other comprehensive loss | 0 | 0 |
Ending balance | 3 | 11 |
Pension and Other Post-retirement Benefit Plans | ||
AOCI Including Portion Attributable to Noncontrolling Interest [Abstract] | ||
Beginning balance | 259 | 267 |
Current-period other comprehensive income (loss) | 0 | 0 |
Amounts reclassified from accumulated other comprehensive loss | (13) | (6) |
Ending balance | 246 | 261 |
Accumulated Other Comprehensive Loss | ||
AOCI Including Portion Attributable to Noncontrolling Interest [Abstract] | ||
Beginning balance | (603) | (244) |
Ending balance | $ (407) | $ (176) |
Stock Incentive Plans - Narrati
Stock Incentive Plans - Narrative (Details) $ in Millions | 3 Months Ended | 9 Months Ended |
Dec. 31, 2020USD ($)shares | Dec. 31, 2020USD ($)anniversaryshares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Plan term | 10 years | |
Total unrecognized compensation expense related to unvested awards, net of expected forfeitures | $ | $ 0 | $ 0 |
Restricted Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of shares to be received (in shares) | shares | 1 | 1 |
Total unrecognized compensation expense related to unvested awards, net of expected forfeitures | $ | $ 146 | $ 146 |
Weighted average period over which cost is expected to be recognized (in years) | 2 years 21 days | |
Restricted Stock Units | Five Years | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Annual installments | 5 years | |
Restricted Stock Units | Ten Years | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Annual installments | 10 years | |
Restricted Stock Units | Fifteen Years | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Annual installments | 15 years | |
Restricted Stock Units | Service-based RSU's | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of anniversaries over which shares are settled | anniversary | 10 | |
Performance-based Restricted Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Vesting period | 3 years | |
Performance period | 3 years | |
Award vesting rights, percentage | 25.00% | |
DXC Share Purchase Plan | Stock purchase plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares purchased under plan (in shares) | shares | 12,232 | 41,425 |
Stock Incentive Plans - Schedul
Stock Incentive Plans - Schedule of Share Based Compensation Shares Authorized (Details) - $ / shares | Dec. 31, 2020 | Mar. 31, 2020 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Reserved for issuance (in shares) | 52,195,000 | |
Available for future grants (in shares) | 33,395,410 | |
DXC Employee Equity Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Reserved for issuance (in shares) | 51,200,000 | |
Available for future grants (in shares) | 32,794,274 | |
DXC Director Equity Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Reserved for issuance (in shares) | 745,000 | |
Available for future grants (in shares) | 435,951 | |
DXC Share Purchase Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Reserved for issuance (in shares) | 250,000 | |
Available for future grants (in shares) | 165,185 |
Stock Incentive Plans - Sched_2
Stock Incentive Plans - Schedule of Options (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Mar. 31, 2020 | |
Additional Disclosures | |||||
Total intrinsic value of options exercised | $ 0 | $ 1 | $ 0 | $ 8 | |
Stock Options | |||||
Number of Option Shares | |||||
Outstanding beginning of period (in shares) | 1,869,815 | ||||
Granted (in shares) | 0 | ||||
Exercised (in shares) | (39,601) | ||||
Canceled/Forfeited (in shares) | 0 | ||||
Expired (in shares) | (82,614) | ||||
Outstanding end of period (in shares) | 1,747,600 | 1,747,600 | 1,869,815 | ||
Weighted Average Exercise Price | |||||
Weighted average exercise price - beginning of period (in dollars per share) | $ 29.92 | ||||
Weighted average exercise price - granted (in dollars per share) | 0 | ||||
Weighted average exercise price - exercised (in dollars per share) | 17.43 | ||||
Weighted average exercise price - canceled/forfeited (in dollars per share) | 0 | ||||
Weighted average exercise price - expired (in dollars per share) | 31.24 | ||||
Weighted average exercise price - end of period (in dollars per share) | $ 30.11 | $ 30.11 | $ 29.92 | ||
Additional Disclosures | |||||
Weighted average remaining contractual life (in years) | 3 years 8 months 23 days | 4 years 3 months 7 days | |||
Aggregate intrinsic value | $ 3 | $ 3 | $ 0 | ||
Total intrinsic value of options exercised | $ 0 | ||||
Vested and Exercisable | |||||
Outstanding (in shares) | 1,747,600 | 1,747,600 | |||
Weighted average exercise price (in dollars per share) | $ 30.11 | $ 30.11 | |||
Weighted average remaining contractual term | 3 years 8 months 23 days | ||||
Aggregate intrinsic value | $ 3 | $ 3 |
Stock Incentive Plans - Sched_3
Stock Incentive Plans - Schedule of RSUs (Details) - Restricted Stock Units | 9 Months Ended |
Dec. 31, 2020$ / sharesshares | |
DXC Employee Equity Plan | |
Number of Shares | |
Equity instruments other than options nonvested - beginning balance (in shares) | shares | 4,174,476 |
Equity instruments other than options nonvested - granted (in shares) | shares | 7,576,602 |
Equity instruments other than options nonvested - settled (in shares) | shares | (1,045,190) |
Equity instruments other than options nonvested - canceled/forfeited (in shares) | shares | (2,042,804) |
Equity instruments other than options nonvested - ending balance (in shares) | shares | 8,663,084 |
Weighted Average Grant Date Fair Value | |
Weighted average fair value other than options - beginning balance (in dollars per share) | $ / shares | $ 55.45 |
Weighted average fair value other than options - granted (in dollars per share) | $ / shares | 18.67 |
Weighted average fair value other than options - settled (in dollars per share) | $ / shares | 50.65 |
Weighted average fair value other than options - canceled/forfeited (in dollars per share) | $ / shares | 36.14 |
Weighted average fair value other than options - ending balance (in dollars per share) | $ / shares | $ 28.43 |
DXC Director Equity Plan | |
Number of Shares | |
Equity instruments other than options nonvested - beginning balance (in shares) | shares | 114,615 |
Equity instruments other than options nonvested - granted (in shares) | shares | 118,500 |
Equity instruments other than options nonvested - settled (in shares) | shares | (48,455) |
Equity instruments other than options nonvested - canceled/forfeited (in shares) | shares | 0 |
Equity instruments other than options nonvested - ending balance (in shares) | shares | 184,660 |
Weighted Average Grant Date Fair Value | |
Weighted average fair value other than options - beginning balance (in dollars per share) | $ / shares | $ 37.69 |
Weighted average fair value other than options - granted (in dollars per share) | $ / shares | 18.82 |
Weighted average fair value other than options - settled (in dollars per share) | $ / shares | 26.90 |
Weighted average fair value other than options - canceled/forfeited (in dollars per share) | $ / shares | 0 |
Weighted average fair value other than options - ending balance (in dollars per share) | $ / shares | $ 28.42 |
Stock Incentive Plans - Sched_4
Stock Incentive Plans - Schedule of Stock-Based Compensation (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Payment Arrangement [Abstract] | ||||
Total share-based compensation cost | $ 6 | $ 9 | $ 42 | $ 57 |
Related income tax benefit | 2 | (3) | 7 | 8 |
Total intrinsic value of options exercised | 0 | 1 | 0 | 8 |
Tax benefits from exercised stock options and awards | $ 1 | $ 3 | $ 5 | $ 13 |
Cash Flows (Details)
Cash Flows (Details) - USD ($) $ in Millions | 9 Months Ended | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | Mar. 31, 2020 | |
Cash paid for: | |||
Interest | $ 262 | $ 277 | |
Taxes on income, net of refunds | 159 | 202 | |
Operating: | |||
ROU assets obtained in exchange for lease, net | 449 | 314 | |
Prepaid assets acquired under long-term financing | 46 | 23 | |
Investing: | |||
Capital expenditures in accounts payable and accrued expenses | 16 | 121 | |
Capital expenditures through finance lease obligations | 277 | 507 | |
Assets acquired under long-term financing | 26 | 282 | |
(Decrease) increase in deferred purchase price receivable | (52) | 58 | |
Contingent consideration | 2 | 19 | |
Financing: | |||
Dividends declared but not yet paid | 0 | 54 | |
Income tax refunds | $ 31 | $ 36 | |
Change in lease classification from operating to finance lease | $ 87 |
Segment Information - Segment M
Segment Information - Segment Measures (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Segment Reporting Information [Line Items] | ||||
Revenues | $ 4,288 | $ 5,021 | $ 13,344 | $ 14,762 |
Segment profit | 300 | 528 | 773 | 1,709 |
Depreciation and amortization | 361 | 333 | 1,078 | 981 |
Amortization of acquired intangible assets | 114 | 146 | 414 | 435 |
Operating segments | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | 4,288 | 5,021 | 13,344 | 14,762 |
Segment profit | 361 | 585 | 952 | 1,893 |
Depreciation and amortization | 334 | 305 | 1,001 | 899 |
Operating segments | GBS | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | 1,921 | 2,359 | 6,337 | 6,803 |
Segment profit | 273 | 353 | 805 | 1,078 |
Depreciation and amortization | 53 | 61 | 162 | 128 |
Operating segments | GIS | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | 2,367 | 2,662 | 7,007 | 7,959 |
Segment profit | 88 | 232 | 147 | 815 |
Depreciation and amortization | 281 | 244 | 839 | 771 |
All Other | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | 0 | 0 | 0 | 0 |
Segment profit | (61) | (57) | (179) | (184) |
Depreciation and amortization | $ 27 | $ 28 | $ 77 | $ 82 |
Segment Information - Reconcili
Segment Information - Reconciliation of Reportable Segment Profit to Consolidated (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Segment Reporting Information [Line Items] | ||||
Segment profit | $ 300 | $ 528 | $ 773 | $ 1,709 |
Interest income | 28 | 33 | 76 | 130 |
Interest expense | (82) | (93) | (284) | (288) |
Restructuring costs | (104) | (74) | (441) | (248) |
Transaction, separation and integration-related costs | (96) | (68) | (307) | (226) |
Amortization of acquired intangible assets | (114) | (146) | (414) | (435) |
Gain on disposition of businesses | 2,046 | 0 | 2,046 | 0 |
Pension and OPEB actuarial and settlement losses | 0 | 0 | (2) | 0 |
Goodwill impairment losses | 0 | (53) | 0 | (2,940) |
Gain on arbitration award | 0 | 0 | 0 | 632 |
Income (loss) before income taxes | 1,978 | 127 | 1,447 | (1,666) |
Operating segments | ||||
Segment Reporting Information [Line Items] | ||||
Segment profit | 361 | 585 | 952 | 1,893 |
All Other | ||||
Segment Reporting Information [Line Items] | ||||
Segment profit | $ (61) | $ (57) | $ (179) | $ (184) |
Commitments and Contingencies_2
Commitments and Contingencies (Details) $ in Millions | 9 Months Ended |
Dec. 31, 2020USD ($) | |
Minimum purchase commitments [Abstract] | |
Remainder of 2021 | $ 1,339 |
2022 | 1,093 |
2023 | 817 |
2024 | 227 |
Total | $ 3,476 |
Minimum | |
Long-term Purchase Commitment [Line Items] | |
Long-term purchase commitment, period | 1 year |
Maximum | |
Long-term Purchase Commitment [Line Items] | |
Long-term purchase commitment, period | 5 years |
Commitments and Contingencies -
Commitments and Contingencies - Guarantor Obligations (Details) $ in Millions | Dec. 31, 2020USD ($) |
Guarantor Obligations [Line Items] | |
Remainder of Fiscal 2021 | $ 87 |
Fiscal 2022 | 281 |
Fiscal 2023 and Thereafter | 645 |
Total | 1,013 |
Surety bonds | |
Guarantor Obligations [Line Items] | |
Remainder of Fiscal 2021 | 14 |
Fiscal 2022 | 93 |
Fiscal 2023 and Thereafter | 87 |
Total | 194 |
Letters of credit | |
Guarantor Obligations [Line Items] | |
Remainder of Fiscal 2021 | 37 |
Fiscal 2022 | 147 |
Fiscal 2023 and Thereafter | 527 |
Total | 711 |
Stand-by letters of credit | |
Guarantor Obligations [Line Items] | |
Remainder of Fiscal 2021 | 36 |
Fiscal 2022 | 41 |
Fiscal 2023 and Thereafter | 31 |
Total | $ 108 |
Commitments and Contingencies_3
Commitments and Contingencies - Contingencies (Details) $ in Thousands | Feb. 21, 2020USD ($) | Aug. 06, 2019USD ($) | Aug. 31, 2020USD ($) | Jul. 31, 2020USD ($) | Dec. 31, 2019plaintiff | Oct. 31, 2019USD ($) | Sep. 30, 2019USD ($) | Jun. 30, 2019USD ($)plaintiff | Mar. 31, 2019lawsuitofficer | Oct. 31, 2018plaintiff | Oct. 31, 2015USD ($) | Oct. 02, 2015administrator | Dec. 31, 2020USD ($)individual | Dec. 31, 2020USD ($) | Feb. 02, 2017joint_venture | Feb. 29, 2016 |
Loss Contingencies [Line Items] | ||||||||||||||||
Number of partially-owned joint ventures involved in possible sanctions law violations | joint_venture | 2 | |||||||||||||||
Strauch Fair Labor Standards Act Collective Action | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Number of plaintiffs | administrator | 4,000 | |||||||||||||||
Number of system administrators filed consents with court to participate in FLSA collective | administrator | 1,000 | |||||||||||||||
Number of individuals involved in collective action | individual | 800 | |||||||||||||||
Amount awarded to plaintiffs | $ 18,750 | $ 8,100 | ||||||||||||||
Loss contingency, damages sought | $ 14,100 | |||||||||||||||
Kemper Corporate Services, Inc. v. Computer Sciences Corporation | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Payments for litigation settlement | $ 60,000 | |||||||||||||||
Amount recovered from insurance carriers | $ 12,500 | |||||||||||||||
In re DXC Technology Company Securities Litigation | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Lawsuits filed | lawsuit | 3 | |||||||||||||||
Perspecta-related Disputes, Separation and Distribution Agreement | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, damages sought | $ 120,000 | |||||||||||||||
Perspecta-related Disputes, Separation and Distribution Agreement, Increase One | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, damages sought | $ 500,000 | |||||||||||||||
Perspecta-related Disputes, Separation and Distribution Agreement, Increase Two | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, damages sought | 800,000 | |||||||||||||||
Perspecta-related Disputes, Separation and Distribution Agreement, Increase Three | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, damages sought | $ 990,000 | |||||||||||||||
Perspecta-related Disputes, IT Services Agreement | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, damages sought | $ 31,000 | $ 39,000 | ||||||||||||||
Settled litigation | Computer Sciences Corporation v. Eric Pulier et al. | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, legal fees percentage | 80.00% | |||||||||||||||
Settled litigation | Kemper Corporate Services, Inc. v. Computer Sciences Corporation | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, damages sought | $ 84,200 | |||||||||||||||
Settled litigation | Forsyth et al. v. HP Inc. and Hewlett Packard Enterprise | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Number of plaintiffs | plaintiff | 142 | |||||||||||||||
Pending litigation | Kemper Corporate Services, Inc. v. Computer Sciences Corporation | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, damages sought | $ 100,000 | |||||||||||||||
Pending litigation | Forsyth et al. v. HP Inc. and Hewlett Packard Enterprise | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Number of plaintiffs | plaintiff | 145 | 16 | ||||||||||||||
Officer | In re DXC Technology Company Securities Litigation | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Number of defendants | officer | 1 | |||||||||||||||
Employees of Former Business Units of HPE | Settled litigation | Forsyth et al. v. HP Inc. and Hewlett Packard Enterprise | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Number of plaintiffs | plaintiff | 35 | 7 |